Pathway Name	Pathway Id	Source Name	Organism	Pathway uploaded gene count	Genes in InnateDB for this entity	Pathway p-value	Pathway p-value (corrected)	Gene Symbols	Genes (Symbol|IDBG-ID|Ensembl|Entrez|Fold Change|P-Value)
Folding of actin by CCT/TriC	13423	REACTOME	9606	7	9	1.946887850002756E-11	1.3277775137018795E-8	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; TCP1; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; 
AndrogenReceptor	15906	NETPATH	9606	19	164	9.913123321529092E-11	3.3803750526414204E-8	AR; CEBPA; EGFR; EP300; ESR1; FOXA1; JUN; NCOA2; NCOA6; NCOR1; NCOR2; NSD1; SIRT1; SMAD3; SP1; SRC; SRY; TOP1; UBE3A; 	AR|IDBG-73722|ENSG00000169083|367|; CEBPA|IDBG-409028|ENSG00000245848|1050|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; FOXA1|IDBG-5104|ENSG00000129514|3169|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; NSD1|IDBG-59534|ENSG00000165671|64324|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SRC|IDBG-74081|ENSG00000197122|6714|; SRY|IDBG-1|ENSG00000184895|6736|; TOP1|IDBG-75139|ENSG00000198900|7150|; UBE3A|IDBG-4274|ENSG00000114062|7337|; 
Formation of tubulin folding intermediates by CCT/TriC	13443	REACTOME	9606	8	21	1.6109456851597596E-9	3.662216524263187E-7	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Prefoldin mediated transfer of substrate  to CCT/TriC	13442	REACTOME	9606	8	27	1.602146591018839E-8	2.1853279501496966E-6	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
TGF_beta_Receptor	15911	NETPATH	9606	19	220	1.4608406024396018E-8	2.490733227159521E-6	AR; CCNB2; EP300; ERBB2IP; ESR1; EWSR1; HGS; HNF4A; JUN; KPNB1; MAP3K7; PPM1A; SHC1; SMAD2; SMAD3; SP1; SRC; TAB1; XPO4; 	AR|IDBG-73722|ENSG00000169083|367|; CCNB2|IDBG-14456|ENSG00000157456|9133|; EP300|IDBG-8992|ENSG00000100393|2033|; ERBB2IP|IDBG-24405|ENSG00000112851|55914|; ESR1|IDBG-97997|ENSG00000091831|2099|; EWSR1|IDBG-3488|ENSG00000182944|2130|; HGS|IDBG-72504|ENSG00000185359|9146|; HNF4A|IDBG-76498|ENSG00000101076|3172|; JUN|IDBG-99221|ENSG00000177606|3725|; KPNB1|IDBG-56053|ENSG00000108424|3837|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SRC|IDBG-74081|ENSG00000197122|6714|; TAB1|IDBG-8281|ENSG00000100324|10454|; XPO4|IDBG-13860|ENSG00000132953|64328|; 
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	18485	REACTOME	9606	8	28	2.208677823030494E-8	2.5105304588446618E-6	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Association of TriC/CCT with target proteins during biosynthesis	13422	REACTOME	9606	8	29	3.003405130657525E-8	2.926174713012046E-6	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; FBXO6; TCP1; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; FBXO6|IDBG-89462|ENSG00000116663|26270|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; 
Circadian Clock	13672	REACTOME	9606	10	55	4.149262097376307E-8	3.5372459380133016E-6	CRY2; CSNK1E; EP300; HDAC3; NCOA2; NCOA6; NCOR1; TBL1X; TBL1XR1; UBC; 	CRY2|IDBG-41167|ENSG00000121671|1408|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cellular responses to stress	16723	REACTOME	9606	19	240	5.980155596672161E-8	4.53162901881157E-6	CBX2; DNAJB1; EEF1A1; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; JUN; POT1; PRDX2; RNF2; SIRT1; SP1; SUZ12; TERF1; TERF2IP; UBC; VHL; YWHAE; 	CBX2|IDBG-71184|ENSG00000173894|84733|; DNAJB1|IDBG-33491|ENSG00000132002|3337|; EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; JUN|IDBG-99221|ENSG00000177606|3725|; POT1|IDBG-39151|ENSG00000128513|25913|; PRDX2|IDBG-31024|ENSG00000167815|7001|; RNF2|IDBG-105369|ENSG00000121481|6045|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SP1|IDBG-36616|ENSG00000185591|6667|; SUZ12|IDBG-39777|ENSG00000178691|23512|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; UBC|IDBG-64029|ENSG00000150991|7316|; VHL|IDBG-17819|ENSG00000134086|7428|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Alpha6Beta4Integrin	15905	NETPATH	9606	11	74	7.613719674653118E-8	5.192556818113426E-6	AR; EGFR; ERBB2IP; JUN; SHC1; SMAD2; SMAD3; SRC; YWHAE; YWHAQ; YWHAZ; 	AR|IDBG-73722|ENSG00000169083|367|; EGFR|IDBG-16933|ENSG00000146648|1956|; ERBB2IP|IDBG-24405|ENSG00000112851|55914|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
NOTCH1 Intracellular Domain Regulates Transcription	13296	REACTOME	9606	9	45	8.456390221914901E-8	5.2429619375872385E-6	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
REV-ERBA represses gene expression	13671	REACTOME	9606	7	24	1.4883546704640687E-7	8.458815710470791E-6	EP300; HDAC3; NCOA2; NCOA6; NCOR1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Chaperonin-mediated protein folding	18121	REACTOME	9606	9	49	1.8425507296980164E-7	9.666304597338824E-6	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; FBXO6; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; FBXO6|IDBG-89462|ENSG00000116663|26270|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Regulation of Telomerase	15864	PID NCI	9606	10	65	2.1730447436505828E-7	9.880110101131317E-6	EGFR; ESR1; JUN; POT1; SMAD3; SP1; TERF1; TERF2IP; UBE3A; YWHAE; 	EGFR|IDBG-16933|ENSG00000146648|1956|; ESR1|IDBG-97997|ENSG00000091831|2099|; JUN|IDBG-99221|ENSG00000177606|3725|; POT1|IDBG-39151|ENSG00000128513|25913|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; UBE3A|IDBG-4274|ENSG00000114062|7337|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
RORA activates circadian gene expression	13668	REACTOME	9606	7	25	2.0358541805937162E-7	9.917518222606532E-6	EP300; HDAC3; NCOA2; NCOA6; NCOR1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
BMAL1:CLOCK,NPAS2 activates circadian gene expression	13670	REACTOME	9606	8	37	2.3881833327952326E-7	1.0179631456039679E-5	CRY2; EP300; HDAC3; NCOA2; NCOA6; NCOR1; TBL1X; TBL1XR1; 	CRY2|IDBG-41167|ENSG00000121671|1408|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
EGFR1	15908	NETPATH	9606	26	472	3.215802444731681E-7	1.2901042748864743E-5	ACTR3; AHCYL1; APP; CEBPA; CYLD; DYNLL1; EEF1A1; EEF1A2; EGFR; EPHB3; ERBB2IP; HGS; HIST3H3; HUWE1; JAK2; JUN; KRAS; NEDD4; RALB; RBM3; SHC1; SMAD2; SMAD3; SP1; SRC; YWHAZ; 	ACTR3|IDBG-67369|ENSG00000115091|10096|; AHCYL1|IDBG-100935|ENSG00000168710|10768|; APP|IDBG-1100|ENSG00000142192|351|; CEBPA|IDBG-409028|ENSG00000245848|1050|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; EEF1A2|IDBG-86175|ENSG00000101210|1917|; EGFR|IDBG-16933|ENSG00000146648|1956|; EPHB3|IDBG-68339|ENSG00000182580|2049|; ERBB2IP|IDBG-24405|ENSG00000112851|55914|; HGS|IDBG-72504|ENSG00000185359|9146|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; HUWE1|IDBG-70116|ENSG00000086758|10075|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; NEDD4|IDBG-13236|ENSG00000069869|4734|; RALB|IDBG-68212|ENSG00000144118|5899|; RBM3|IDBG-63532|ENSG00000102317|5935|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Chromatin modifying enzymes	19015	REACTOME	9606	16	193	3.765696249446134E-7	1.3516867590117176E-5	CHD3; CHD4; EP300; GPS2; HDAC3; HIST2H2AC; HIST2H2BE; JAK2; KDM5D; MBIP; NCOR1; NCOR2; SMARCB1; TBL1X; TBL1XR1; WDR5; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; EP300|IDBG-8992|ENSG00000100393|2033|; GPS2|IDBG-24467|ENSG00000132522|2874|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; JAK2|IDBG-47039|ENSG00000096968|3717|; KDM5D|IDBG-354|ENSG00000012817|8284|; MBIP|IDBG-4937|ENSG00000151332|51562|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Chromatin organization	18782	REACTOME	9606	16	193	3.765696249446134E-7	1.3516867590117176E-5	CHD3; CHD4; EP300; GPS2; HDAC3; HIST2H2AC; HIST2H2BE; JAK2; KDM5D; MBIP; NCOR1; NCOR2; SMARCB1; TBL1X; TBL1XR1; WDR5; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; EP300|IDBG-8992|ENSG00000100393|2033|; GPS2|IDBG-24467|ENSG00000132522|2874|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; JAK2|IDBG-47039|ENSG00000096968|3717|; KDM5D|IDBG-354|ENSG00000012817|8284|; MBIP|IDBG-4937|ENSG00000151332|51562|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
HDACs deacetylate histones	18573	REACTOME	9606	10	70	4.4547364108377813E-7	1.4467286819958889E-5	CHD3; CHD4; GPS2; HDAC3; HIST2H2AC; HIST2H2BE; NCOR1; NCOR2; TBL1X; TBL1XR1; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; GPS2|IDBG-24467|ENSG00000132522|2874|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Regulation of nuclear SMAD2/3 signaling	15480	PID NCI	9606	10	70	4.4547364108377813E-7	1.4467286819958889E-5	AR; EP300; ESR1; HNF4A; JUN; NCOA2; NCOR1; SMAD2; SMAD3; SP1; 	AR|IDBG-73722|ENSG00000169083|367|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; HNF4A|IDBG-76498|ENSG00000101076|3172|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOR1|IDBG-31971|ENSG00000141027|9611|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Protein folding	16650	REACTOME	9606	9	55	5.195944454827795E-7	1.6107427809966164E-5	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; FBXO6; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; FBXO6|IDBG-89462|ENSG00000116663|26270|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Regulation of nuclear beta catenin signaling and target gene transcription	15295	PID NCI	9606	10	72	5.836643411315158E-7	1.730691655007364E-5	AR; CHD8; EP300; IGF2BP1; JUN; NCOA2; TBL1X; TBL1XR1; TLE1; TLE2; 	AR|IDBG-73722|ENSG00000169083|367|; CHD8|IDBG-2645|ENSG00000100888|57680|; EP300|IDBG-8992|ENSG00000100393|2033|; IGF2BP1|IDBG-57431|ENSG00000159217|10642|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOA2|IDBG-24827|ENSG00000140396|10499|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; 
Transcriptional regulation of white adipocyte differentiation	13879	REACTOME	9606	10	77	1.1046312905665193E-6	3.138993917359859E-5	CEBPA; EGR2; EP300; HDAC3; NCOA2; NCOA6; NCOR1; NCOR2; TBL1X; TBL1XR1; 	CEBPA|IDBG-409028|ENSG00000245848|1050|; EGR2|IDBG-75626|ENSG00000122877|1959|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Wnt signaling pathway	445	KEGG	9606	13	140	1.3654929344129992E-6	3.7250647250786615E-5	CHD8; CSNK1E; CSNK2A1; DAAM2; EP300; JUN; LRP5; LRP6; MAP3K7; SMAD3; TBL1X; TBL1XR1; TBL1Y; 	CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DAAM2|IDBG-86252|ENSG00000146122|23500|; EP300|IDBG-8992|ENSG00000100393|2033|; JUN|IDBG-99221|ENSG00000177606|3725|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TBL1Y|IDBG-67|ENSG00000092377|90665|; 
Telomere Maintenance	17962	REACTOME	9606	9	64	1.9575806055783164E-6	4.9447036037200435E-5	HIST2H2AC; HIST2H2BE; HIST3H3; PCNA; POT1; PRIM1; PRIM2; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; PCNA|IDBG-50801|ENSG00000132646|5111|; POT1|IDBG-39151|ENSG00000128513|25913|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
Validated nuclear estrogen receptor alpha network	15063	PID NCI	9606	9	64	1.9575806055783164E-6	4.9447036037200435E-5	APBB1; EP300; ESR1; ESR2; JUN; NCOA2; NCOR1; NCOR2; PCNA; 	APBB1|IDBG-28785|ENSG00000166313|322|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; ESR2|IDBG-9004|ENSG00000140009|2100|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PCNA|IDBG-50801|ENSG00000132646|5111|; 
RNF mutants show enhanced WNT signaling and proliferation	19131	REACTOME	9606	15	197	2.5934439780032404E-6	5.527277478119406E-5	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
TCF dependent signaling in response to WNT	18732	REACTOME	9606	15	197	2.5934439780032404E-6	5.527277478119406E-5	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
XAV939 inhibits tankyrase, stabilizing AXIN	19487	REACTOME	9606	15	197	2.5934439780032404E-6	5.527277478119406E-5	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	16943	REACTOME	9606	15	197	2.5934439780032404E-6	5.527277478119406E-5	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Downregulation of SMAD2/3:SMAD4 transcriptional activity	13269	REACTOME	9606	6	23	2.4967284555443383E-6	6.08131716671871E-5	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; UBC|IDBG-64029|ENSG00000150991|7316|; 
FBXW7 Mutants and NOTCH1 in Cancer	17874	REACTOME	9606	9	70	4.212414071585023E-6	7.182165992052465E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1	19096	REACTOME	9606	9	70	4.212414071585023E-6	7.182165992052465E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 HD Domain Mutants in Cancer	19129	REACTOME	9606	9	70	4.212414071585023E-6	7.182165992052465E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	18776	REACTOME	9606	9	70	4.212414071585023E-6	7.182165992052465E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 PEST Domain Mutants in Cancer	18501	REACTOME	9606	9	70	4.212414071585023E-6	7.182165992052465E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 in Cancer	17392	REACTOME	9606	9	70	4.212414071585023E-6	7.182165992052465E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	16917	REACTOME	9606	9	70	4.212414071585023E-6	7.182165992052465E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Developmental Biology	16794	REACTOME	9606	25	502	3.50546775144947E-6	7.244633352995572E-5	ACTG1; ACTR3; AKT2; CACNB3; CEBPA; CSNK2A1; DPYSL2; DPYSL5; EGFR; EGR2; EP300; EPHB3; HDAC3; JAK2; KRAS; NCOA2; NCOA6; NCOR1; NCOR2; SMAD2; SMAD3; TBL1X; TBL1XR1; TCF12; TUBA4A; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ACTR3|IDBG-67369|ENSG00000115091|10096|; AKT2|IDBG-51270|ENSG00000105221|208|; CACNB3|IDBG-30418|ENSG00000167535|784|; CEBPA|IDBG-409028|ENSG00000245848|1050|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; EGFR|IDBG-16933|ENSG00000146648|1956|; EGR2|IDBG-75626|ENSG00000122877|1959|; EP300|IDBG-8992|ENSG00000100393|2033|; EPHB3|IDBG-68339|ENSG00000182580|2049|; HDAC3|IDBG-50725|ENSG00000171720|8841|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TCF12|IDBG-13567|ENSG00000140262|6938|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Wnt signaling pathway	16165	INOH	9606	10	91	5.204675503308991E-6	8.65753339818715E-5	CSNK1E; EP300; LRP5; LRP6; MAP3K7; TLE1; TLE2; YWHAE; YWHAQ; YWHAZ; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EP300|IDBG-8992|ENSG00000100393|2033|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Gene Expression	19770	REACTOME	9606	41	1118	5.911811764226627E-6	9.59965624572038E-5	AR; CHD3; CHD4; EEF1A1; EEF1A2; EIF1AX; EIF2B2; EIF5; EIF5B; ESR1; ESR2; HIST2H2AC; HIST2H2BE; HNF4A; HNRNPF; HNRNPK; HNRNPL; IGF2BP1; NCOA2; NCOA6; NCOR1; NCOR2; PCBP1; PPM1A; RBMX; RPS4Y1; SIRT1; SMAD2; SMAD3; SP1; SRSF3; SRSF9; SUZ12; TBL1X; TBL1XR1; UBC; YWHAZ; ZNF208; ZNF317; ZNF331; ZNF746; 	AR|IDBG-73722|ENSG00000169083|367|; CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; EEF1A2|IDBG-86175|ENSG00000101210|1917|; EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF2B2|IDBG-12676|ENSG00000119718|8892|; EIF5|IDBG-21484|ENSG00000100664|1983|; EIF5B|IDBG-63343|ENSG00000158417|9669|; ESR1|IDBG-97997|ENSG00000091831|2099|; ESR2|IDBG-9004|ENSG00000140009|2100|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HNF4A|IDBG-76498|ENSG00000101076|3172|; HNRNPF|IDBG-71348|ENSG00000169813|3185|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; HNRNPL|IDBG-49631|ENSG00000104824|3191|; IGF2BP1|IDBG-57431|ENSG00000159217|10642|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PCBP1|IDBG-55131|ENSG00000169564|5093|; PPM1A|IDBG-8210|ENSG00000100614|5494|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; SUZ12|IDBG-39777|ENSG00000178691|23512|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; ZNF208|IDBG-41056|ENSG00000160321|7757|; ZNF317|IDBG-25519|ENSG00000130803|57693|; ZNF331|IDBG-67685|ENSG00000130844|55422|; ZNF746|IDBG-47452|ENSG00000181220|155061|; 
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	18119	REACTOME	9606	7	42	8.818568805067353E-6	1.3986660290827755E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by WNT in cancer	17000	REACTOME	9606	15	219	9.50615446318021E-6	1.4734539417929327E-4	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
ErbB4 signaling events	15100	PID NCI	9606	6	30	1.322167952281197E-5	2.0038189854572805E-4	JAK2; NCOR1; NEDD4; SHC1; TAB2; WWOX; 	JAK2|IDBG-47039|ENSG00000096968|3717|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NEDD4|IDBG-13236|ENSG00000069869|4734|; SHC1|IDBG-103007|ENSG00000160691|6464|; TAB2|IDBG-97690|ENSG00000055208|23118|; WWOX|IDBG-43129|ENSG00000186153|51741|; 
Presenilin action in Notch and Wnt signaling	15094	PID NCI	9606	7	46	1.646336195023333E-5	2.4408723587085067E-4	CSNK2A1; JUN; LRP6; MAP3K7; NEDD4; TAB1; TLE1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JUN|IDBG-99221|ENSG00000177606|3725|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NEDD4|IDBG-13236|ENSG00000069869|4734|; TAB1|IDBG-8281|ENSG00000100324|10454|; TLE1|IDBG-73128|ENSG00000196781|7088|; 
IRAK2 mediated activation of TAK1 complex	13033	REACTOME	9606	4	10	1.9864368196972136E-5	2.7094998220669996E-4	MAP3K7; TAB1; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	13038	REACTOME	9606	4	10	1.9864368196972136E-5	2.7094998220669996E-4	MAP3K7; TAB1; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Chromosome Maintenance	17495	REACTOME	9606	9	84	1.9201539319203688E-5	2.7282187116035243E-4	HIST2H2AC; HIST2H2BE; HIST3H3; PCNA; POT1; PRIM1; PRIM2; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; PCNA|IDBG-50801|ENSG00000132646|5111|; POT1|IDBG-39151|ENSG00000128513|25913|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
RANKL	15925	NETPATH	9606	9	84	1.9201539319203688E-5	2.7282187116035243E-4	AKT2; CYLD; EGFR; JUN; MAP3K7; SPI1; SRC; TAB1; TAB2; 	AKT2|IDBG-51270|ENSG00000105221|208|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SPI1|IDBG-43260|ENSG00000066336|6688|; SRC|IDBG-74081|ENSG00000197122|6714|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
Cell Cycle	18205	REACTOME	9606	24	523	2.20813941374568E-5	2.8960597695664494E-4	CCNB2; CSNK1E; CSNK2A1; DBF4; DYNLL1; EP300; GMNN; HIST2H2AC; HIST2H2BE; HIST3H3; MCM2; MIS12; NUDC; ODF2; PCNA; POT1; PRIM1; PRIM2; RAD51; TERF1; TERF2IP; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DBF4|IDBG-25283|ENSG00000006634|10926|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; EP300|IDBG-8992|ENSG00000100393|2033|; GMNN|IDBG-65780|ENSG00000112312|51053|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; MCM2|IDBG-54871|ENSG00000073111|4171|; MIS12|IDBG-21731|ENSG00000167842|79003|; NUDC|IDBG-94765|ENSG00000090273|10726|; ODF2|IDBG-88092|ENSG00000136811|4957|; PCNA|IDBG-50801|ENSG00000132646|5111|; POT1|IDBG-39151|ENSG00000128513|25913|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; RAD51|IDBG-6509|ENSG00000051180|5888|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Tgf beta signaling pathway	4035	PID BIOCARTA	9606	5	20	2.2622479537504562E-5	2.9110435933166244E-4	EP300; MAP3K7; SMAD2; SMAD3; TAB1; 	EP300|IDBG-8992|ENSG00000100393|2033|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Regulation of Androgen receptor activity	15656	PID NCI	9606	7	48	2.1969075575046434E-5	2.9378254004277783E-4	AR; CEBPA; JUN; NCOA2; SIRT1; SRC; SRY; 	AR|IDBG-73722|ENSG00000169083|367|; CEBPA|IDBG-409028|ENSG00000245848|1050|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOA2|IDBG-24827|ENSG00000140396|10499|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SRC|IDBG-74081|ENSG00000197122|6714|; SRY|IDBG-1|ENSG00000184895|6736|; 
deactivation of the beta-catenin transactivating complex	17798	REACTOME	9606	6	33	2.3578231238118335E-5	2.977843278591982E-4	AKT2; CHD8; TLE1; TLE2; UBC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Signaling by NOTCH	18790	REACTOME	9606	10	109	2.609920113150994E-5	3.236300940307233E-4	EP300; HDAC3; JUN; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TNFalpha	15913	NETPATH	9606	16	270	2.915607937119259E-5	3.550793951991669E-4	AKT2; CSNK2A1; EGFR; EP300; HIST3H3; JUN; MAP3K7; SMAD2; SMAD3; SMARCB1; SRC; TAB1; TAB2; YWHAE; YWHAQ; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; SRC|IDBG-74081|ENSG00000197122|6714|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Packaging Of Telomere Ends	12919	REACTOME	9606	6	35	3.353471139567835E-5	4.01239880207941E-4	HIST2H2AC; HIST2H2BE; HIST3H3; POT1; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
Signaling by ERBB4	13265	REACTOME	9606	11	137	3.6062260730804156E-5	4.2404244514497304E-4	AKT2; EGFR; ESR1; JAK2; KRAS; NCOR1; NEDD4; SHC1; TAB2; UBC; WWOX; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NEDD4|IDBG-13236|ENSG00000069869|4734|; SHC1|IDBG-103007|ENSG00000160691|6464|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; WWOX|IDBG-43129|ENSG00000186153|51741|; 
Cellular Senescence	18630	REACTOME	9606	12	164	4.005767072644212E-5	4.630395158548055E-4	CBX2; HIST2H2AC; HIST2H2BE; HIST3H3; JUN; POT1; RNF2; SP1; SUZ12; TERF1; TERF2IP; UBC; 	CBX2|IDBG-71184|ENSG00000173894|84733|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; JUN|IDBG-99221|ENSG00000177606|3725|; POT1|IDBG-39151|ENSG00000128513|25913|; RNF2|IDBG-105369|ENSG00000121481|6045|; SP1|IDBG-36616|ENSG00000185591|6667|; SUZ12|IDBG-39777|ENSG00000178691|23512|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of cytoplasmic and nuclear SMAD2/3 signaling	15659	PID NCI	9606	4	12	4.5513807608813656E-5	5.173402798201819E-4	KPNB1; PPM1A; SMAD2; SMAD3; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Adherens junction	505	KEGG	9606	8	73	4.781328633050143E-5	5.345682176623274E-4	ACTG1; CSNK2A1; EGFR; EP300; MAP3K7; SMAD2; SMAD3; SRC; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Pelp1 modulation of estrogen receptor activity	3957	PID BIOCARTA	9606	3	5	5.645936732438241E-5	6.111950557972826E-4	EP300; ESR1; SRC; 	EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Leptin	15926	NETPATH	9606	9	96	5.618118742579469E-5	6.179930616837416E-4	CSNK2A1; EGFR; EP300; ESR1; JAK2; MAPT; SHC1; SP1; SRC; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAPT|IDBG-55163|ENSG00000186868|4137|; SHC1|IDBG-103007|ENSG00000160691|6464|; SP1|IDBG-36616|ENSG00000185591|6667|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	13720	REACTOME	9606	7	56	6.128267591160478E-5	6.429966918725301E-4	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Constitutive Signaling by NOTCH1 PEST Domain Mutants	13718	REACTOME	9606	7	56	6.128267591160478E-5	6.429966918725301E-4	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Activation of BH3-only proteins	18409	REACTOME	9606	5	25	7.204747889745474E-5	7.444906152736991E-4	AKT2; DYNLL1; YWHAE; YWHAQ; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Signaling by Wnt	17272	REACTOME	9606	16	294	8.112815134182674E-5	8.258119285839677E-4	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; MAP3K7; TLE1; TLE2; UBC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Cell cycle	473	KEGG	9606	10	126	9.058035842780648E-5	9.084677124671179E-4	CCNB2; DBF4; EP300; MCM2; PCNA; SMAD2; SMAD3; YWHAE; YWHAQ; YWHAZ; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; DBF4|IDBG-25283|ENSG00000006634|10926|; EP300|IDBG-8992|ENSG00000100393|2033|; MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Activation of BAD and translocation to mitochondria 	13399	REACTOME	9606	4	15	1.2028706969739363E-4	0.001155433542727077	AKT2; YWHAE; YWHAQ; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Calcium signaling by hbx of hepatitis b virus	4105	PID BIOCARTA	9606	4	15	1.2028706969739363E-4	0.001155433542727077	CSNK2A1; JUN; SHC1; SRC; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
TRAF6 mediated induction of TAK1 complex	13025	REACTOME	9606	4	15	1.2028706969739363E-4	0.001155433542727077	MAP3K7; TAB1; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Role of erbb2 in signal transduction and oncology	4019	PID BIOCARTA	9606	5	28	1.275503601340923E-4	0.0011916348713897388	EGFR; EP300; ESR1; JAK2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Transcriptional activation of mitochondrial biogenesis	18752	REACTOME	9606	6	44	1.2747641880863245E-4	0.001207484967048435	HDAC3; NCOA2; NCOA6; NCOR1; TBL1X; TBL1XR1; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	13458	REACTOME	9606	9	109	1.5116359941002363E-4	0.0013931564161842717	EP300; HDAC3; NCOA2; NCOA6; NCOR1; NCOR2; SP1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
TAK1 activates NFkB by phosphorylation and activation of IKKs complex	13027	REACTOME	9606	5	30	1.79619405788796E-4	0.0016118478256310375	APP; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Wnt signaling pathway	4172	PID BIOCARTA	9606	5	30	1.79619405788796E-4	0.0016118478256310375	CSNK2A1; LRP6; MAP3K7; TAB1; TLE1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TLE1|IDBG-73128|ENSG00000196781|7088|; 
Cell Cycle, Mitotic	19119	REACTOME	9606	20	454	1.954929349907601E-4	0.0017093100213294663	CCNB2; CSNK1E; CSNK2A1; DBF4; DYNLL1; EP300; GMNN; HIST2H2AC; HIST2H2BE; HIST3H3; MCM2; MIS12; NUDC; ODF2; PCNA; PRIM1; PRIM2; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DBF4|IDBG-25283|ENSG00000006634|10926|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; EP300|IDBG-8992|ENSG00000100393|2033|; GMNN|IDBG-65780|ENSG00000112312|51053|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; MCM2|IDBG-54871|ENSG00000073111|4171|; MIS12|IDBG-21731|ENSG00000167842|79003|; NUDC|IDBG-94765|ENSG00000090273|10726|; ODF2|IDBG-88092|ENSG00000136811|4957|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Pancreatic cancer	593	KEGG	9606	7	67	1.9450924448016391E-4	0.0017227961653957377	AKT2; EGFR; KRAS; RAD51; RALB; SMAD2; SMAD3; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; RAD51|IDBG-6509|ENSG00000051180|5888|; RALB|IDBG-68212|ENSG00000144118|5899|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	18305	REACTOME	9606	6	50	2.6238474327614625E-4	0.0018836462622561236	APP; CYLD; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of cholesterol biosynthesis by SREBP (SREBF)	13470	REACTOME	9606	6	50	2.6238474327614625E-4	0.0018836462622561236	KPNB1; NCOA2; NCOA6; SP1; TBL1X; TBL1XR1; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Signaling by constitutively active EGFR	13690	REACTOME	9606	4	18	2.5845553155314876E-4	0.001895340564723091	EGFR; KRAS; SHC1; UBC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Function of SMAD2/3 in Cancer	17055	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Function of SMAD4 in Cancer	17027	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Function of TGFBR1 in Cancer	19193	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Function of TGFBR2 in Cancer	18204	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
SMAD2/3 MH2 Domain Mutants in Cancer	18188	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
SMAD2/3 Phosphorylation Motif Mutants in Cancer	18488	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
SMAD4 MH2 Domain Mutants in Cancer	16763	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by TGF-beta Receptor Complex	19869	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by TGF-beta Receptor Complex in Cancer	17260	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TGFBR1 KD Mutants in Cancer	18966	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TGFBR1 LBD Mutants in Cancer	19248	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TGFBR2 Kinase Domain Mutants in Cancer	19454	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TGFBR2 MSI Frameshift Mutants in Cancer	17966	REACTOME	9606	7	70	2.5622093357284293E-4	0.0018993769206160746	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of retinoblastoma protein	15024	PID NCI	9606	6	49	2.343678937632951E-4	0.00202327726008313	HDAC3; JUN; PAX3; SIRT1; SMARCB1; SPI1; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; JUN|IDBG-99221|ENSG00000177606|3725|; PAX3|IDBG-82144|ENSG00000135903|5077|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; SPI1|IDBG-43260|ENSG00000066336|6688|; 
TGF-beta signaling	16255	INOH	9606	9	120	3.1294552806446734E-4	0.002223217188957987	EP300; HDAC3; JUN; MAP3K7; SMAD2; SMAD3; TAB1; TLE1; TLE2; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TAB1|IDBG-8281|ENSG00000100324|10454|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; 
Mitochondrial biogenesis	17433	REACTOME	9606	6	53	3.6249330911480474E-4	0.002548664297075225	HDAC3; NCOA2; NCOA6; NCOR1; TBL1X; TBL1XR1; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
NOD1/2 Signaling Pathway	13056	REACTOME	9606	5	35	3.8037538003804277E-4	0.002647102134550461	CYLD; MAP3K7; TAB1; TAB2; UBC; 	CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	13023	REACTOME	9606	4	20	3.978264480091184E-4	0.002686313242992265	MAP3K7; TAB1; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
SHC1 events in EGFR signaling	13213	REACTOME	9606	4	20	3.978264480091184E-4	0.002686313242992265	EGFR; JAK2; KRAS; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
p73 transcription factor network	15377	PID NCI	9606	7	75	3.9333418951031956E-4	0.0027096355277377573	AEN; EP300; PIN1; RAD51; SIRT1; SP1; WWOX; 	AEN|IDBG-28670|ENSG00000181026|64782|; EP300|IDBG-8992|ENSG00000100393|2033|; PIN1|IDBG-26087|ENSG00000127445|5300|; RAD51|IDBG-6509|ENSG00000051180|5888|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SP1|IDBG-36616|ENSG00000185591|6667|; WWOX|IDBG-43129|ENSG00000186153|51741|; 
Notch	15907	NETPATH	9606	7	76	4.2673929961201785E-4	0.0028532961013274134	APP; EP300; JAK2; NCOR1; NCOR2; SMAD3; SRC; 	APP|IDBG-1100|ENSG00000142192|351|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SRC|IDBG-74081|ENSG00000197122|6714|; 
FOXA1 transcription factor network	15723	PID NCI	9606	5	36	4.353320971152868E-4	0.0028824901964332583	AR; ESR1; FOXA1; JUN; SP1; 	AR|IDBG-73722|ENSG00000169083|367|; ESR1|IDBG-97997|ENSG00000091831|2099|; FOXA1|IDBG-5104|ENSG00000129514|3169|; JUN|IDBG-99221|ENSG00000177606|3725|; SP1|IDBG-36616|ENSG00000185591|6667|; 
EGF signaling pathway 	16203	INOH	9606	4	21	4.8454801163331184E-4	0.0031472547041325586	EGFR; JUN; KRAS; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
activated TAK1 mediates p38 MAPK activation	13024	REACTOME	9606	4	21	4.8454801163331184E-4	0.0031472547041325586	MAP3K7; TAB1; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of PLK1 Activity at G2/M Transition	12974	REACTOME	9606	7	78	5.003439746640229E-4	0.0031595795437117	CCNB2; CSNK1E; DYNLL1; ODF2; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Activation of gene expression by SREBF (SREBP)	13469	REACTOME	9606	5	37	4.960693225406942E-4	0.0031618624109603123	NCOA2; NCOA6; SP1; TBL1X; TBL1XR1; 	NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Nuclear signaling by ERBB4	13262	REACTOME	9606	5	37	4.960693225406942E-4	0.0031618624109603123	ESR1; JAK2; NCOR1; TAB2; WWOX; 	ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TAB2|IDBG-97690|ENSG00000055208|23118|; WWOX|IDBG-43129|ENSG00000186153|51741|; 
Cellular response to heat stress	18841	REACTOME	9606	5	38	5.629689294761248E-4	0.003490407362751974	DNAJB1; EEF1A1; EP300; SIRT1; YWHAE; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; EP300|IDBG-8992|ENSG00000100393|2033|; SIRT1|IDBG-75847|ENSG00000096717|23411|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Intrinsic Pathway for Apoptosis	19328	REACTOME	9606	5	38	5.629689294761248E-4	0.003490407362751974	AKT2; DYNLL1; YWHAE; YWHAQ; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Generic Transcription Pathway	13742	REACTOME	9606	19	458	5.999246623135713E-4	0.0036860236008815824	AR; ESR1; ESR2; HNF4A; NCOA2; NCOA6; NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; TBL1X; TBL1XR1; UBC; ZNF208; ZNF317; ZNF331; ZNF746; 	AR|IDBG-73722|ENSG00000169083|367|; ESR1|IDBG-97997|ENSG00000091831|2099|; ESR2|IDBG-9004|ENSG00000140009|2100|; HNF4A|IDBG-76498|ENSG00000101076|3172|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; ZNF208|IDBG-41056|ENSG00000160321|7757|; ZNF317|IDBG-25519|ENSG00000130803|57693|; ZNF331|IDBG-67685|ENSG00000130844|55422|; ZNF746|IDBG-47452|ENSG00000181220|155061|; 
Prolactin	15931	NETPATH	9606	8	105	6.078952580619051E-4	0.0037016479106983862	EGFR; EP300; ESR1; JAK2; JUN; SHC1; SRC; YWHAZ; 	EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
MAP kinase activation in TLR cascade	18088	REACTOME	9606	6	59	6.506576007812928E-4	0.003892530559060015	JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Meiotic synapsis	12911	REACTOME	9606	6	59	6.506576007812928E-4	0.003892530559060015	HIST2H2AC; HIST2H2BE; HIST3H3; POT1; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
PPARA activates gene expression	13457	REACTOME	9606	8	107	6.892985497863465E-4	0.0040878400952546814	EP300; HDAC3; NCOA2; NCOA6; NCOR1; SP1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
MyD88 cascade initiated on plasma membrane	13043	REACTOME	9606	7	83	7.291525401407351E-4	0.004214254511660859	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 10 (TLR10) Cascade	13044	REACTOME	9606	7	83	7.291525401407351E-4	0.004214254511660859	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 5 (TLR5) Cascade	13048	REACTOME	9606	7	83	7.291525401407351E-4	0.004214254511660859	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	13040	REACTOME	9606	7	84	7.835284848878377E-4	0.004490474173895003	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Mechanism of gene regulation by peroxisome proliferators via ppara	3965	PID BIOCARTA	9606	5	41	8.045916068513885E-4	0.004572762298938725	EP300; JUN; NCOR1; NCOR2; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Signaling by Interleukins	18744	REACTOME	9606	8	110	8.276801607072929E-4	0.004589250972377022	JAK2; KRAS; MAP3K7; SHC1; TAB1; TAB2; UBC; YWHAZ; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Plasma membrane estrogen receptor signaling	15557	PID NCI	9606	4	24	8.246719683076144E-4	0.004610051494965517	ESR1; ESR2; SHC1; SRC; 	ESR1|IDBG-97997|ENSG00000091831|2099|; ESR2|IDBG-9004|ENSG00000140009|2100|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Tpo signaling pathway	4124	PID BIOCARTA	9606	4	24	8.246719683076144E-4	0.004610051494965517	CSNK2A1; JAK2; JUN; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
IL6	15922	NETPATH	9606	7	85	8.410627545709173E-4	0.004625845150140045	AR; EP300; JAK2; JUN; MAP3K7; MAPT; SHC1; 	AR|IDBG-73722|ENSG00000169083|367|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; MAPT|IDBG-55163|ENSG00000186868|4137|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
DNA Damage/Telomere Stress Induced Senescence	18208	REACTOME	9606	6	62	8.490062456776703E-4	0.00463217807641737	HIST2H2AC; HIST2H2BE; HIST3H3; POT1; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
MyD88 dependent cascade initiated on endosome	13041	REACTOME	9606	7	86	9.018836395131023E-4	0.004843186158645164	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 7/8 (TLR7/8) Cascade	16831	REACTOME	9606	7	86	9.018836395131023E-4	0.004843186158645164	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cytokine Signaling in Immune system	17418	REACTOME	9606	13	267	0.0010903173859406748	0.005809347321965158	ARIH1; ICAM1; JAK2; KPNB1; KRAS; MAP3K7; NEDD4; PIN1; SHC1; TAB1; TAB2; UBC; YWHAZ; 	ARIH1|IDBG-20750|ENSG00000166233|25820|; ICAM1|IDBG-26804|ENSG00000090339|3383|; JAK2|IDBG-47039|ENSG00000096968|3717|; KPNB1|IDBG-56053|ENSG00000108424|3837|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NEDD4|IDBG-13236|ENSG00000069869|4734|; PIN1|IDBG-26087|ENSG00000127445|5300|; SHC1|IDBG-103007|ENSG00000160691|6464|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Toll Like Receptor 9 (TLR9) Cascade	13042	REACTOME	9606	7	89	0.0011053877393824678	0.005843987893479403	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
FSH	15929	NETPATH	9606	5	44	0.001116222071357542	0.0058558727128141825	AKT2; EGFR; HIST3H3; SRC; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
formation of the beta-catenin:TCF transactivating complex	19208	REACTOME	9606	6	66	0.001182449427628543	0.006155958088875315	EP300; HIST2H2AC; HIST2H2BE; HIST3H3; TLE1; TLE2; 	EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; 
Meiosis	19435	REACTOME	9606	7	92	0.0013433355013890253	0.006836976208562054	HIST2H2AC; HIST2H2BE; HIST3H3; POT1; RAD51; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; RAD51|IDBG-6509|ENSG00000051180|5888|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
MyD88:Mal cascade initiated on plasma membrane	13034	REACTOME	9606	7	92	0.0013433355013890253	0.006836976208562054	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor TLR6:TLR2 Cascade	13036	REACTOME	9606	7	92	0.0013433355013890253	0.006836976208562054	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
LPA receptor mediated events	15008	PID NCI	9606	5	46	0.0013685463185372343	0.006913693253647362	EGFR; JUN; MAPT; SLC9A3R2; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; MAPT|IDBG-55163|ENSG00000186868|4137|; SLC9A3R2|IDBG-9763|ENSG00000065054|9351|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Agrin in postsynaptic differentiation	4033	PID BIOCARTA	9606	5	47	0.0015093956519019198	0.007249350947866967	ACTA1; EGFR; JUN; SP1; SRC; 	ACTA1|IDBG-107311|ENSG00000143632|58|; EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; SP1|IDBG-36616|ENSG00000185591|6667|; SRC|IDBG-74081|ENSG00000197122|6714|; 
TGF-beta receptor signaling	15571	PID NCI	9606	5	47	0.0015093956519019198	0.007249350947866967	MAP3K7; SHC1; SMAD2; SMAD3; YWHAE; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
G2/M Transition	18803	REACTOME	9606	8	120	0.0014576705382797882	0.0072564328985898945	CCNB2; CSNK1E; DYNLL1; EP300; ODF2; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; EP300|IDBG-8992|ENSG00000100393|2033|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Erythropoietin mediated neuroprotection through nf-kb	4161	PID BIOCARTA	9606	3	13	0.001451172200675446	0.007277201771034222	EP300; JAK2; JUN; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; 
ErbB2/ErbB3 signaling events	15442	PID NCI	9606	4	28	0.0015021100567720468	0.007317421847989542	JAK2; JUN; SHC1; SRC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
SHC1 events in ERBB2 signaling	13289	REACTOME	9606	4	28	0.0015021100567720468	0.007317421847989542	EGFR; JAK2; KRAS; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
YAP1- and WWTR1 (TAZ)-stimulated gene expression	13740	REACTOME	9606	4	28	0.0015021100567720468	0.007317421847989542	NCOA2; NCOA6; TBL1X; TBL1XR1; 	NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Mitotic G2-G2/M phases	19400	REACTOME	9606	8	122	0.0016203402514793084	0.0076211865621302645	CCNB2; CSNK1E; DYNLL1; EP300; ODF2; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; EP300|IDBG-8992|ENSG00000100393|2033|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Toll Like Receptor 2 (TLR2) Cascade	17710	REACTOME	9606	7	95	0.0016195952174077534	0.0076705829046672756	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor TLR1:TLR2 Cascade	13035	REACTOME	9606	7	95	0.0016195952174077534	0.0076705829046672756	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Internalization of ErbB1	15162	PID NCI	9606	4	29	0.0017181458336611403	0.00802585930518423	EGFR; HGS; SHC1; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; HGS|IDBG-72504|ENSG00000185359|9146|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
MyD88-independent cascade 	13030	REACTOME	9606	7	97	0.001827047560512106	0.008039009266253267	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Oxidative Stress Induced Senescence	19575	REACTOME	9606	7	97	0.001827047560512106	0.008039009266253267	CBX2; HIST2H2AC; HIST2H2BE; JUN; RNF2; SUZ12; UBC; 	CBX2|IDBG-71184|ENSG00000173894|84733|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; JUN|IDBG-99221|ENSG00000177606|3725|; RNF2|IDBG-105369|ENSG00000121481|6045|; SUZ12|IDBG-39777|ENSG00000178691|23512|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TRIF-mediated TLR3/TLR4 signaling 	19507	REACTOME	9606	7	97	0.001827047560512106	0.008039009266253267	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 3 (TLR3) Cascade	13031	REACTOME	9606	7	97	0.001827047560512106	0.008039009266253267	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Circadian rhythm pathway	15497	PID NCI	9606	3	14	0.0018225460786748728	0.008231631957988499	CRY2; CSNK1E; WDR5; 	CRY2|IDBG-41167|ENSG00000121671|1408|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Leading Strand Synthesis	12953	REACTOME	9606	3	14	0.0018225460786748728	0.008231631957988499	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Polymerase switching	12951	REACTOME	9606	3	14	0.0018225460786748728	0.008231631957988499	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Polymerase switching on the C-strand of the telomere	12914	REACTOME	9606	3	14	0.0018225460786748728	0.008231631957988499	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Removal of the Flap Intermediate	12949	REACTOME	9606	3	14	0.0018225460786748728	0.008231631957988499	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Activation of the pre-replicative complex	12957	REACTOME	9606	4	30	0.0019548422071626595	0.00843798978028439	DBF4; MCM2; PRIM1; PRIM2; 	DBF4|IDBG-25283|ENSG00000006634|10926|; MCM2|IDBG-54871|ENSG00000073111|4171|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	13270	REACTOME	9606	4	30	0.0019548422071626595	0.00843798978028439	SMAD2; SMAD3; SP1; UBC; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Vegf hypoxia and angiogenesis	3979	PID BIOCARTA	9606	4	30	0.0019548422071626595	0.00843798978028439	ACTA1; SHC1; SRC; VHL; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Signaling events mediated by HDAC Class I	15280	PID NCI	9606	5	50	0.0019960769693775017	0.008561789264877084	CHD3; CHD4; HDAC3; NCOR1; NCOR2; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
IL4	15920	NETPATH	9606	6	74	0.0021412565759286037	0.009127106154895674	CEBPA; EP300; HIST3H3; JAK2; SHC1; SPI1; 	CEBPA|IDBG-409028|ENSG00000245848|1050|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; SPI1|IDBG-43260|ENSG00000066336|6688|; 
IL1-mediated signaling events	15122	PID NCI	9606	4	31	0.0022131809574027416	0.00931721859844858	JUN; MAP3K7; TAB1; TAB2; 	JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
Signalling to RAS	13184	REACTOME	9606	4	31	0.0022131809574027416	0.00931721859844858	JAK2; KRAS; RALB; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells	3941	PID BIOCARTA	9606	3	15	0.0022481108309346763	0.00934885113839908	HDAC3; NCOA2; NCOR2; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
Validated nuclear estrogen receptor beta network	15034	PID NCI	9606	3	15	0.0022481108309346763	0.00934885113839908	ESR2; NCOA2; SMARCB1; 	ESR2|IDBG-9004|ENSG00000140009|2100|; NCOA2|IDBG-24827|ENSG00000140396|10499|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; 
Disease	19807	REACTOME	9606	35	1192	0.002306772084070067	0.009534657947489611	AKT2; APP; CHD8; CSNK1E; CSNK2A1; CUL3; EGFR; EP300; HDAC3; HGS; HIST2H2AC; HIST2H2BE; HIST3H3; HS2ST1; JAK2; KPNB1; KRAS; LRP5; LRP6; NCOR1; NCOR2; PPM1A; PRPS1; RPS4Y1; SHC1; SMAD2; SMAD3; SP1; SV2B; TBL1X; TBL1XR1; TLE1; TLE2; UBC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HGS|IDBG-72504|ENSG00000185359|9146|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; HS2ST1|IDBG-100108|ENSG00000153936|9653|; JAK2|IDBG-47039|ENSG00000096968|3717|; KPNB1|IDBG-56053|ENSG00000108424|3837|; KRAS|IDBG-23889|ENSG00000133703|3845|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; PRPS1|IDBG-81487|ENSG00000147224|5631|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SV2B|IDBG-30872|ENSG00000185518|9899|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Keratinocyte differentiation	4032	PID BIOCARTA	9606	5	52	0.002378528841643813	0.00977202813253663	CEBPA; EGFR; JUN; SHC1; SP1; 	CEBPA|IDBG-409028|ENSG00000245848|1050|; EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SP1|IDBG-36616|ENSG00000185591|6667|; 
DNA strand elongation	19139	REACTOME	9606	4	32	0.002494133431478963	0.010185622756099718	MCM2; PCNA; PRIM1; PRIM2; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Translocation of GLUT4 to the plasma membrane	13827	REACTOME	9606	6	77	0.0026214783615180572	0.010641953824734018	ACTG1; AKT2; TUBA4A; YWHAE; YWHAQ; YWHAZ; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; AKT2|IDBG-51270|ENSG00000105221|208|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Eukaryotic protein translation	4055	PID BIOCARTA	9606	3	16	0.0027304141454425838	0.010826409576696757	EIF1AX; EIF5; EIF5B; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF5|IDBG-21484|ENSG00000100664|1983|; EIF5B|IDBG-63343|ENSG00000158417|9669|; 
Hypoxia-inducible factor in the cardivascular system	3949	PID BIOCARTA	9606	3	16	0.0027304141454425838	0.010826409576696757	EP300; JUN; VHL; 	EP300|IDBG-8992|ENSG00000100393|2033|; JUN|IDBG-99221|ENSG00000177606|3725|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Nongenotropic Androgen signaling	14920	PID NCI	9606	3	16	0.0027304141454425838	0.010826409576696757	AR; SHBG; SRC; 	AR|IDBG-73722|ENSG00000169083|367|; SHBG|IDBG-26209|ENSG00000129214|6462|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Processive synthesis on the lagging strand	12950	REACTOME	9606	3	16	0.0027304141454425838	0.010826409576696757	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Validated transcriptional targets of TAp63 isoforms	15683	PID NCI	9606	5	54	0.002811671069010265	0.01102045786818966	AEN; EGR2; EP300; SP1; YWHAQ; 	AEN|IDBG-28670|ENSG00000181026|64782|; EGR2|IDBG-75626|ENSG00000122877|1959|; EP300|IDBG-8992|ENSG00000100393|2033|; SP1|IDBG-36616|ENSG00000185591|6667|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Alpha4 beta1 integrin signaling events	15573	PID NCI	9606	4	33	0.002798658934766377	0.011032863546304445	CD81; IGSF8; SRC; YWHAZ; 	CD81|IDBG-22455|ENSG00000110651|975|; IGSF8|IDBG-103984|ENSG00000162729|93185|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
DNA Replication	16645	REACTOME	9606	7	105	0.002870473443621777	0.01118664507742887	DBF4; GMNN; MCM2; PCNA; PRIM1; PRIM2; UBC; 	DBF4|IDBG-25283|ENSG00000006634|10926|; GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Acetylation and deacetylation of rela in nucleus	4016	PID BIOCARTA	9606	2	5	0.003131844860992019	0.011999540422452567	EP300; HDAC3; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; 
Angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling	4049	PID BIOCARTA	9606	4	34	0.0031277032309376673	0.012051376290957564	EGFR; JUN; SHC1; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Signaling events mediated by HDAC Class II	15366	PID NCI	9606	4	34	0.0031277032309376673	0.012051376290957564	ESR1; HDAC3; NCOR2; YWHAE; 	ESR1|IDBG-97997|ENSG00000091831|2099|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR2|IDBG-63911|ENSG00000196498|9612|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Map kinase inactivation of smrt corepressor	4027	PID BIOCARTA	9606	3	17	0.003271813913630035	0.01239653938386491	EGFR; NCOR2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Nerve growth factor pathway (ngf)	4099	PID BIOCARTA	9606	3	17	0.003271813913630035	0.01239653938386491	CSNK2A1; JUN; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Pathogenic Escherichia coli infection	434	KEGG	9606	5	56	0.0032992055993698636	0.012431260877183685	ACTG1; TUBA4A; TUBB8; YWHAQ; YWHAZ; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; TUBB8|IDBG-777287|ENSG00000261456|347688|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Signal transduction through il1r	4064	PID BIOCARTA	9606	4	35	0.00348219714723247	0.012977368603347238	JUN; MAP3K7; TAB1; TAB2; 	JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
Toll-like receptor pathway	3951	PID BIOCARTA	9606	4	35	0.00348219714723247	0.012977368603347238	JUN; MAP3K7; TAB1; TAB2; 	JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
DNA Replication Pre-Initiation	17908	REACTOME	9606	6	82	0.003595818498035833	0.013255936300867233	DBF4; GMNN; MCM2; PRIM1; PRIM2; UBC; 	DBF4|IDBG-25283|ENSG00000006634|10926|; GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
M/G1 Transition	18934	REACTOME	9606	6	82	0.003595818498035833	0.013255936300867233	DBF4; GMNN; MCM2; PRIM1; PRIM2; UBC; 	DBF4|IDBG-25283|ENSG00000006634|10926|; GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Activated TLR4 signalling	19190	REACTOME	9606	7	110	0.003723185402367751	0.013651679808681753	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling events mediated by TCPTP	15420	PID NCI	9606	4	36	0.0038630552784343804	0.014088789838995976	EGFR; KPNB1; SHC1; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; KPNB1|IDBG-56053|ENSG00000108424|3837|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
mRNA Splicing	19346	REACTOME	9606	7	111	0.003914656418474938	0.014125903055025965	HNRNPF; HNRNPK; HNRNPL; PCBP1; RBMX; SRSF3; SRSF9; 	HNRNPF|IDBG-71348|ENSG00000169813|3185|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; HNRNPL|IDBG-49631|ENSG00000104824|3191|; PCBP1|IDBG-55131|ENSG00000169564|5093|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
mRNA Splicing - Major Pathway	13745	REACTOME	9606	7	111	0.003914656418474938	0.014125903055025965	HNRNPF; HNRNPK; HNRNPL; PCBP1; RBMX; SRSF3; SRSF9; 	HNRNPF|IDBG-71348|ENSG00000169813|3185|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; HNRNPL|IDBG-49631|ENSG00000104824|3191|; PCBP1|IDBG-55131|ENSG00000169564|5093|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
Fc epsilon receptor (FCERI) signaling	17802	REACTOME	9606	9	173	0.0041083543410735755	0.014746829792695676	AKT2; EGFR; JAK2; JUN; KRAS; MAP3K7; TAB1; TAB2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
DNA replication	441	KEGG	9606	4	37	0.004271174788155143	0.01509295961410263	MCM2; PCNA; PRIM1; PRIM2; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
FCERI mediated NF-kB activation	16799	REACTOME	9606	4	37	0.004271174788155143	0.01509295961410263	MAP3K7; TAB1; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
FOXM1 transcription factor network	15700	PID NCI	9606	4	37	0.004271174788155143	0.01509295961410263	CCNB2; ESR1; GAS1; SP1; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; ESR1|IDBG-97997|ENSG00000091831|2099|; GAS1|IDBG-74874|ENSG00000180447|2619|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Insulin receptor signaling	16186	INOH	9606	6	85	0.0042966302948190425	0.015104648768384469	AKT2; KRAS; SHC1; YWHAE; YWHAQ; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
IL4-mediated signaling events	15439	PID NCI	9606	5	60	0.004452259764011301	0.01549204672987606	EGR2; JAK2; SHC1; SP1; SPI1; 	EGR2|IDBG-75626|ENSG00000122877|1959|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; SP1|IDBG-36616|ENSG00000185591|6667|; SPI1|IDBG-43260|ENSG00000066336|6688|; 
Validated targets of C-MYC transcriptional repression	15263	PID NCI	9606	5	60	0.004452259764011301	0.01549204672987606	CEBPA; EP300; HDAC3; SP1; SPI1; 	CEBPA|IDBG-409028|ENSG00000245848|1050|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; SP1|IDBG-36616|ENSG00000185591|6667|; SPI1|IDBG-43260|ENSG00000066336|6688|; 
GRB2 events in EGFR signaling	13214	REACTOME	9606	3	19	0.004540429328026488	0.01571864366352317	EGFR; JAK2; KRAS; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
DNA replication initiation	12948	REACTOME	9606	2	6	0.004642058838757411	0.01582942064016277	PRIM1; PRIM2; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Telomere C-strand synthesis initiation	12915	REACTOME	9606	2	6	0.004642058838757411	0.01582942064016277	PRIM1; PRIM2; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Fatty acid, triacylglycerol, and ketone body metabolism	13534	REACTOME	9606	9	176	0.004597809606654209	0.015836899756253388	EP300; HDAC3; NCOA2; NCOA6; NCOR1; NCOR2; SP1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Loss of Nlp from mitotic centrosomes	12976	REACTOME	9606	5	61	0.0047802894935736785	0.01605988884047906	CSNK1E; DYNLL1; ODF2; TUBA4A; YWHAE; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Loss of proteins required for interphase microtubule organization?from the centrosome	12977	REACTOME	9606	5	61	0.0047802894935736785	0.01605988884047906	CSNK1E; DYNLL1; ODF2; TUBA4A; YWHAE; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Processing of Capped Intron-Containing Pre-mRNA	13751	REACTOME	9606	7	115	0.004756241352354283	0.016138092548784184	HNRNPF; HNRNPK; HNRNPL; PCBP1; RBMX; SRSF3; SRSF9; 	HNRNPF|IDBG-71348|ENSG00000169813|3185|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; HNRNPL|IDBG-49631|ENSG00000104824|3191|; PCBP1|IDBG-55131|ENSG00000169564|5093|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
Igf-1 signaling pathway	4168	PID BIOCARTA	9606	3	20	0.005271476895029462	0.017284361742356216	CSNK2A1; JUN; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Regulation of HSF1-mediated heat shock response	17076	REACTOME	9606	3	20	0.005271476895029462	0.017284361742356216	DNAJB1; SIRT1; YWHAE; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; SIRT1|IDBG-75847|ENSG00000096717|23411|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
SHC-mediated signalling	13279	REACTOME	9606	3	20	0.005271476895029462	0.017284361742356216	JAK2; KRAS; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Sprouty regulation of tyrosine kinase signals	4142	PID BIOCARTA	9606	3	20	0.005271476895029462	0.017284361742356216	EGFR; SHC1; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Nuclear Receptor transcription pathway	13739	REACTOME	9606	4	39	0.005172692882333769	0.01729302228309623	AR; ESR1; ESR2; HNF4A; 	AR|IDBG-73722|ENSG00000169083|367|; ESR1|IDBG-97997|ENSG00000091831|2099|; ESR2|IDBG-9004|ENSG00000140009|2100|; HNF4A|IDBG-76498|ENSG00000101076|3172|; 
ErbB signaling pathway	461	KEGG	9606	6	89	0.005381901350924825	0.017561993881965218	AKT2; EGFR; JUN; KRAS; SHC1; SRC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Colorectal cancer	442	KEGG	9606	5	63	0.005487259861607749	0.017736072159319834	AKT2; JUN; KRAS; SMAD2; SMAD3; 	AKT2|IDBG-51270|ENSG00000105221|208|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Wnt	15912	NETPATH	9606	7	118	0.005471990107354812	0.017770939301028486	CSNK1E; JUN; LRP5; LRP6; MAP3K7; PIN1; SRC; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; JUN|IDBG-99221|ENSG00000177606|3725|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; PIN1|IDBG-26087|ENSG00000127445|5300|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Signaling by ERBB2	13291	REACTOME	9606	8	149	0.005559905006561351	0.017886109502239816	AKT2; EGFR; ERBB2IP; JAK2; KRAS; SHC1; SRC; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; ERBB2IP|IDBG-24405|ENSG00000112851|55914|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IL-1 signaling pathway 	16110	INOH	9606	4	40	0.005667789103014456	0.01814756886505098	JUN; MAP3K7; TAB1; TAB2; 	JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
BMP2 signaling	16264	INOH	9606	5	64	0.0058671008854315225	0.018610989785415342	EP300; MAP3K7; SMAD2; SMAD3; TAB1; 	EP300|IDBG-8992|ENSG00000100393|2033|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
HIF-1-alpha transcription factor network	15518	PID NCI	9606	5	64	0.0058671008854315225	0.018610989785415342	HNF4A; JUN; NCOA2; SMAD3; SP1; 	HNF4A|IDBG-76498|ENSG00000101076|3172|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOA2|IDBG-24827|ENSG00000140396|10499|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; 
IL3-mediated signaling events	15527	PID NCI	9606	3	21	0.006069298375579653	0.01890073740705627	JAK2; SHC1; YWHAZ; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Lagging Strand Synthesis	19630	REACTOME	9606	3	21	0.006069298375579653	0.01890073740705627	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
PDGFR-alpha signaling pathway	15770	PID NCI	9606	3	21	0.006069298375579653	0.01890073740705627	CSNK2A1; JUN; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
regulation of FZD by ubiquitination	18257	REACTOME	9606	3	21	0.006069298375579653	0.01890073740705627	LRP5; LRP6; UBC; 	LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signalling to ERKs	18748	REACTOME	9606	4	41	0.006193540183693598	0.019199974569450152	JAK2; KRAS; RALB; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Downregulation of ERBB4 signaling	13264	REACTOME	9606	2	7	0.00642192698311413	0.01981789231893139	NEDD4; UBC; 	NEDD4|IDBG-13236|ENSG00000069869|4734|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 4 (TLR4) Cascade	13046	REACTOME	9606	7	122	0.00654847336912394	0.020117382151993365	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Pathways in cancer	4397	KEGG	9606	13	329	0.00662657726982441	0.02026603452027017	AKT2; AR; CEBPA; EGFR; EP300; JUN; KRAS; RAD51; RALB; SMAD2; SMAD3; SPI1; VHL; 	AKT2|IDBG-51270|ENSG00000105221|208|; AR|IDBG-73722|ENSG00000169083|367|; CEBPA|IDBG-409028|ENSG00000245848|1050|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; RAD51|IDBG-6509|ENSG00000051180|5888|; RALB|IDBG-68212|ENSG00000144118|5899|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SPI1|IDBG-43260|ENSG00000066336|6688|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Toll-like receptor signaling pathway 	16121	INOH	9606	4	42	0.006750741216091084	0.020553596023991604	JUN; MAP3K7; TAB1; TAB2; 	JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
GMCSF-mediated signaling events	15598	PID NCI	9606	3	22	0.006935408665859113	0.021021994267181845	JAK2; SHC1; YWHAZ; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Apoptosis	17979	REACTOME	9606	8	155	0.007016028984622884	0.02117226445802127	AKT2; DYNLL1; KPNB1; MAPT; UBC; YWHAE; YWHAQ; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; KPNB1|IDBG-56053|ENSG00000108424|3837|; MAPT|IDBG-55163|ENSG00000186868|4137|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
AP-1 transcription factor network	15318	PID NCI	9606	5	67	0.007117370726871999	0.02128967910406449	ACTA1; EP300; ESR1; JUN; SP1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; JUN|IDBG-99221|ENSG00000177606|3725|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)	14943	PID NCI	9606	5	67	0.007117370726871999	0.02128967910406449	HGS; JUN; KPNB1; SHC1; SRC; 	HGS|IDBG-72504|ENSG00000185359|9146|; JUN|IDBG-99221|ENSG00000177606|3725|; KPNB1|IDBG-56053|ENSG00000108424|3837|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Interleukin-1 signaling	13078	REACTOME	9606	4	43	0.007340164457664268	0.021577552414340652	MAP3K7; TAB1; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Notch-mediated HES/HEY network	15284	PID NCI	9606	4	43	0.007340164457664268	0.021577552414340652	AR; EP300; JAK2; TLE1; 	AR|IDBG-73722|ENSG00000169083|367|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; TLE1|IDBG-73128|ENSG00000196781|7088|; 
PDGF signaling pathway	16259	INOH	9606	4	43	0.007340164457664268	0.021577552414340652	AKT2; JUN; KRAS; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
TCR	15915	NETPATH	9606	11	259	0.007288373679729723	0.02170598624268852	ACTA1; DNAJB1; DPYSL2; ERBB2IP; HGS; JUN; SHC1; SRC; TUBA4A; YWHAQ; YWHAZ; 	ACTA1|IDBG-107311|ENSG00000143632|58|; DNAJB1|IDBG-33491|ENSG00000132002|3337|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; ERBB2IP|IDBG-24405|ENSG00000112851|55914|; HGS|IDBG-72504|ENSG00000185359|9146|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Antiviral mechanism by IFN-stimulated genes	17226	REACTOME	9606	5	68	0.007572496168599453	0.021976350582914157	ARIH1; KPNB1; NEDD4; PIN1; UBC; 	ARIH1|IDBG-20750|ENSG00000166233|25820|; KPNB1|IDBG-56053|ENSG00000108424|3837|; NEDD4|IDBG-13236|ENSG00000069869|4734|; PIN1|IDBG-26087|ENSG00000127445|5300|; UBC|IDBG-64029|ENSG00000150991|7316|; 
ISG15 antiviral mechanism	13075	REACTOME	9606	5	68	0.007572496168599453	0.021976350582914157	ARIH1; KPNB1; NEDD4; PIN1; UBC; 	ARIH1|IDBG-20750|ENSG00000166233|25820|; KPNB1|IDBG-56053|ENSG00000108424|3837|; NEDD4|IDBG-13236|ENSG00000069869|4734|; PIN1|IDBG-26087|ENSG00000127445|5300|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Renal cell carcinoma	483	KEGG	9606	5	68	0.007572496168599453	0.021976350582914157	AKT2; EP300; JUN; KRAS; VHL; 	AKT2|IDBG-51270|ENSG00000105221|208|; EP300|IDBG-8992|ENSG00000100393|2033|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; VHL|IDBG-17819|ENSG00000134086|7428|; 
SHC-related events	16715	REACTOME	9606	3	23	0.007871173766733457	0.02255521222232024	JAK2; KRAS; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
SHC-related events triggered by IGF1R	13283	REACTOME	9606	3	23	0.007871173766733457	0.02255521222232024	JAK2; KRAS; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Telomere C-strand (Lagging Strand) Synthesis	12918	REACTOME	9606	3	23	0.007871173766733457	0.02255521222232024	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Cbl mediated ligand-induced downregulation of egf receptors pathway	4065	PID BIOCARTA	9606	2	8	0.008461324551812553	0.023944495204714363	EGFR; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SRC|IDBG-74081|ENSG00000197122|6714|; 
EGFR Transactivation by Gastrin	13218	REACTOME	9606	2	8	0.008461324551812553	0.023944495204714363	EGFR; KRAS; 	EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
WNT mediated activation of DVL	16827	REACTOME	9606	2	8	0.008461324551812553	0.023944495204714363	CSNK1E; CSNK2A1; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; 
IL1	15917	NETPATH	9606	5	70	0.008542863378874343	0.024075342249554967	EIF2AK3; JUN; MAP3K7; TAB1; TAB2; 	EIF2AK3|IDBG-60518|ENSG00000172071|9451|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
Oncostatin_M	16513	NETPATH	9606	4	45	0.008618648681851929	0.024089829512389405	EP300; JAK2; SHC1; SRC; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Signaling events mediated by PTP1B	15198	PID NCI	9606	4	45	0.008618648681851929	0.024089829512389405	EGFR; JAK2; SHC1; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Class I PI3K signaling events mediated by Akt	15022	PID NCI	9606	3	24	0.008877816880895641	0.024512838513242218	AKT2; SRC; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Fas signaling pathway	16231	INOH	9606	3	24	0.008877816880895641	0.024512838513242218	YWHAE; YWHAQ; YWHAZ; 	YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Retinoic acid receptors-mediated signaling	15413	PID NCI	9606	3	24	0.008877816880895641	0.024512838513242218	HDAC3; NCOA2; NCOR2; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
Leishmaniasis	10355	KEGG	9606	5	71	0.009058940002710378	0.024912085007453542	JAK2; JUN; MAP3K7; TAB1; TAB2; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
Cellular response to hypoxia	18542	REACTOME	9606	3	25	0.009956424317330334	0.026839056855412206	EP300; UBC; VHL; 	EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Downregulation of TGF-beta receptor signaling	13267	REACTOME	9606	3	25	0.009956424317330334	0.026839056855412206	SMAD2; SMAD3; UBC; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; UBC|IDBG-64029|ENSG00000150991|7316|; 
EGFR downregulation	13215	REACTOME	9606	3	25	0.009956424317330334	0.026839056855412206	EGFR; HGS; UBC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; HGS|IDBG-72504|ENSG00000185359|9146|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of Hypoxia-inducible Factor (HIF) by oxygen	18380	REACTOME	9606	3	25	0.009956424317330334	0.026839056855412206	EP300; UBC; VHL; 	EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; VHL|IDBG-17819|ENSG00000134086|7428|; 
SHC1 events in ERBB4 signaling	13261	REACTOME	9606	3	25	0.009956424317330334	0.026839056855412206	JAK2; KRAS; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Osteoclast differentiation	10367	KEGG	9606	7	133	0.010320080660113164	0.02760115690273403	AKT2; CYLD; JUN; MAP3K7; SPI1; TAB1; TAB2; 	AKT2|IDBG-51270|ENSG00000105221|208|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SPI1|IDBG-43260|ENSG00000066336|6688|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
Spliceosome	8120	KEGG	9606	7	133	0.010320080660113164	0.02760115690273403	HNRNPK; PCBP1; PRPF31; RBMX; SRSF3; SRSF9; TRA2B; 	HNRNPK|IDBG-73948|ENSG00000165119|3190|; PCBP1|IDBG-55131|ENSG00000169564|5093|; PRPF31|IDBG-68110|ENSG00000105618|26121|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; TRA2B|IDBG-68708|ENSG00000136527|6434|; 
Interleukin-3, 5 and GM-CSF signaling	13082	REACTOME	9606	4	48	0.010795969869447648	0.02842799788016717	JAK2; SHC1; UBC; YWHAZ; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Immune System	18444	REACTOME	9606	31	1127	0.010777902994561194	0.028490425745312922	ACTG1; ACTR3; AKT2; APP; ARIH1; CD81; CUL3; CYLD; DYNLL1; DZIP3; EGFR; EP300; FBXO6; HUWE1; ICAM1; JAK2; JUN; KPNB1; KRAS; MAP3K7; NCKIPSD; NEDD4; PIN1; SHC1; TAB1; TAB2; TUBA4A; UBC; UBE3A; VHL; YWHAZ; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ACTR3|IDBG-67369|ENSG00000115091|10096|; AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; ARIH1|IDBG-20750|ENSG00000166233|25820|; CD81|IDBG-22455|ENSG00000110651|975|; CUL3|IDBG-82331|ENSG00000036257|8452|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; DZIP3|IDBG-49039|ENSG00000198919|9666|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HUWE1|IDBG-70116|ENSG00000086758|10075|; ICAM1|IDBG-26804|ENSG00000090339|3383|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; KPNB1|IDBG-56053|ENSG00000108424|3837|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NCKIPSD|IDBG-239383|ENSG00000213672|51517|; NEDD4|IDBG-13236|ENSG00000069869|4734|; PIN1|IDBG-26087|ENSG00000127445|5300|; SHC1|IDBG-103007|ENSG00000160691|6464|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
EGFR-dependent Endothelin signaling events	15405	PID NCI	9606	2	9	0.010750401016476572	0.028528301530105143	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Role of ppar-gamma coactivators in obesity and thermogenesis	4034	PID BIOCARTA	9606	2	9	0.010750401016476572	0.028528301530105143	EP300; NCOA2; 	EP300|IDBG-8992|ENSG00000100393|2033|; NCOA2|IDBG-24827|ENSG00000140396|10499|; 
Links between pyk2 and map kinases	4153	PID BIOCARTA	9606	3	26	0.01110795121162735	0.029025374430382576	JUN; SHC1; SRC; 	JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Pdgf signaling pathway	4071	PID BIOCARTA	9606	3	26	0.01110795121162735	0.029025374430382576	CSNK2A1; JUN; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
RNA transport	10361	KEGG	9606	8	170	0.011909067879036962	0.03099994005153896	EEF1A1; EEF1A2; EIF1AX; EIF1AY; EIF2B2; EIF5; EIF5B; KPNB1; 	EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; EEF1A2|IDBG-86175|ENSG00000101210|1917|; EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF1AY|IDBG-384|ENSG00000198692|9086|; EIF2B2|IDBG-12676|ENSG00000119718|8892|; EIF5|IDBG-21484|ENSG00000100664|1983|; EIF5B|IDBG-63343|ENSG00000158417|9669|; KPNB1|IDBG-56053|ENSG00000108424|3837|; 
Control of gene expression by vitamin d receptor	4029	PID BIOCARTA	9606	3	27	0.012333227065072165	0.03174060701275176	EP300; NCOA2; NCOR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOR1|IDBG-31971|ENSG00000141027|9611|; 
GRB2 events in ERBB2 signaling	13287	REACTOME	9606	3	27	0.012333227065072165	0.03174060701275176	EGFR; JAK2; KRAS; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Multi-step regulation of transcription by pitx2	4152	PID BIOCARTA	9606	3	27	0.012333227065072165	0.03174060701275176	CSNK2A1; EP300; LRP6; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EP300|IDBG-8992|ENSG00000100393|2033|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
C-MYB transcription factor network	15398	PID NCI	9606	5	78	0.013285449826767447	0.03368281331544758	CEBPA; MAP3K7; NCOR1; SP1; SPI1; 	CEBPA|IDBG-409028|ENSG00000245848|1050|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NCOR1|IDBG-31971|ENSG00000141027|9611|; SP1|IDBG-36616|ENSG00000185591|6667|; SPI1|IDBG-43260|ENSG00000066336|6688|; 
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	13017	REACTOME	9606	5	78	0.013285449826767447	0.03368281331544758	APP; CYLD; EP300; PIN1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; EP300|IDBG-8992|ENSG00000100393|2033|; PIN1|IDBG-26087|ENSG00000127445|5300|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll-Like Receptors Cascades	17767	REACTOME	9606	7	140	0.013424490845458673	0.033909269468899314	APP; JAK2; JUN; MAP3K7; TAB1; TAB2; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
LIF signaling	16169	INOH	9606	2	10	0.013279573551038634	0.033920109220255984	EP300; JAK2; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Overview of telomerase protein component gene htert transcriptional regulation	3983	PID BIOCARTA	9606	2	10	0.013279573551038634	0.033920109220255984	ESR1; SP1; 	ESR1|IDBG-97997|ENSG00000091831|2099|; SP1|IDBG-36616|ENSG00000185591|6667|; 
BARD1 signaling events	15606	PID NCI	9606	3	28	0.01363296110583795	0.03405743397136074	EWSR1; PCNA; RAD51; 	EWSR1|IDBG-3488|ENSG00000182944|2130|; PCNA|IDBG-50801|ENSG00000132646|5111|; RAD51|IDBG-6509|ENSG00000051180|5888|; 
Endothelins	15358	PID NCI	9606	3	28	0.01363296110583795	0.03405743397136074	JAK2; JUN; SRC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Nfkb activation by nontypeable hemophilus influenzae	4159	PID BIOCARTA	9606	3	28	0.01363296110583795	0.03405743397136074	EP300; MAP3K7; SMAD3; 	EP300|IDBG-8992|ENSG00000100393|2033|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Centrosome maturation	18712	REACTOME	9606	5	79	0.013981508201016058	0.03454850939526431	CSNK1E; DYNLL1; ODF2; TUBA4A; YWHAE; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Recruitment of mitotic centrosome proteins and complexes	12979	REACTOME	9606	5	79	0.013981508201016058	0.03454850939526431	CSNK1E; DYNLL1; ODF2; TUBA4A; YWHAE; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
G1/S Transition	17967	REACTOME	9606	6	109	0.013981390147026426	0.034800394453547524	DBF4; MCM2; PCNA; PRIM1; PRIM2; UBC; 	DBF4|IDBG-25283|ENSG00000006634|10926|; MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Extension of Telomeres	19607	REACTOME	9606	3	29	0.015007747483672227	0.03655458494237306	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
HIF-2-alpha transcription factor network	15324	PID NCI	9606	3	29	0.015007747483672227	0.03655458494237306	SIRT1; SP1; VHL; 	SIRT1|IDBG-75847|ENSG00000096717|23411|; SP1|IDBG-36616|ENSG00000185591|6667|; VHL|IDBG-17819|ENSG00000134086|7428|; 
IGF1 pathway	15262	PID NCI	9606	3	29	0.015007747483672227	0.03655458494237306	SHC1; YWHAE; YWHAZ; 	SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Lissencephaly gene (LIS1) in neuronal migration and development	15729	PID NCI	9606	3	29	0.015007747483672227	0.03655458494237306	CSNK2A1; NUDC; YWHAE; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; NUDC|IDBG-94765|ENSG00000090273|10726|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Cell to cell adhesion signaling	4013	PID BIOCARTA	9606	2	11	0.01603952066389732	0.03798247601659018	ACTA1; SRC; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Condensation of Prometaphase Chromosomes	12938	REACTOME	9606	2	11	0.01603952066389732	0.03798247601659018	CCNB2; CSNK2A1; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; 
Epo signaling pathway	4020	PID BIOCARTA	9606	2	11	0.01603952066389732	0.03798247601659018	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
IL-5 signaling	16159	INOH	9606	2	11	0.01603952066389732	0.03798247601659018	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Regulation of eif2	4041	PID BIOCARTA	9606	2	11	0.01603952066389732	0.03798247601659018	EIF2AK3; EIF5; 	EIF2AK3|IDBG-60518|ENSG00000172071|9451|; EIF5|IDBG-21484|ENSG00000100664|1983|; 
Regulation of transcriptional activity by pml	3937	PID BIOCARTA	9606	2	11	0.01603952066389732	0.03798247601659018	PAX3; SIRT1; 	PAX3|IDBG-82144|ENSG00000135903|5077|; SIRT1|IDBG-75847|ENSG00000096717|23411|; 
Signaling mediated by p38-gamma and p38-delta	15207	PID NCI	9606	2	11	0.01603952066389732	0.03798247601659018	MAPT; SNTA1; 	MAPT|IDBG-55163|ENSG00000186868|4137|; SNTA1|IDBG-66573|ENSG00000101400|6640|; 
Mcalpain and friends in cell motility	4086	PID BIOCARTA	9606	3	30	0.01645807029202775	0.03883876795558106	ACTA1; EGFR; SHC1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Translation	17867	REACTOME	9606	7	145	0.01601843036083473	0.03887747155191917	EEF1A1; EEF1A2; EIF1AX; EIF2B2; EIF5; EIF5B; RPS4Y1; 	EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; EEF1A2|IDBG-86175|ENSG00000101210|1917|; EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF2B2|IDBG-12676|ENSG00000119718|8892|; EIF5|IDBG-21484|ENSG00000100664|1983|; EIF5B|IDBG-63343|ENSG00000158417|9669|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
IGF1R signaling cascade	19000	REACTOME	9606	5	83	0.017010596455378477	0.03973022870742507	AKT2; JAK2; KRAS; PPM1A; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Insulin receptor signalling cascade	18606	REACTOME	9606	5	83	0.017010596455378477	0.03973022870742507	AKT2; JAK2; KRAS; PPM1A; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	13284	REACTOME	9606	5	83	0.017010596455378477	0.03973022870742507	AKT2; JAK2; KRAS; PPM1A; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
RMTs methylate histone arginines	18864	REACTOME	9606	4	55	0.01717423480333655	0.039975522648039344	HIST2H2AC; JAK2; SMARCB1; WDR5; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; JAK2|IDBG-47039|ENSG00000096968|3717|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Arf6 signaling events	15819	PID NCI	9606	3	31	0.017984308434845643	0.04129730085038629	EGFR; SRC; USP6; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SRC|IDBG-74081|ENSG00000197122|6714|; USP6|IDBG-21050|ENSG00000129204|9098|; 
Bcr signaling pathway	4023	PID BIOCARTA	9606	3	31	0.017984308434845643	0.04129730085038629	CSNK2A1; JUN; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
TGF-beta receptor signaling activates SMADs	13268	REACTOME	9606	3	31	0.017984308434845643	0.04129730085038629	SMAD2; SMAD3; UBC; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IL3	15919	NETPATH	9606	5	84	0.017830715985744004	0.041362409191419765	JAK2; SHC1; SRC; YWHAQ; YWHAZ; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
ATF-2 transcription factor network	15253	PID NCI	9606	4	56	0.01824154474181903	0.0414691117130686	CUL3; EP300; ESR1; JUN; 	CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; JUN|IDBG-99221|ENSG00000177606|3725|; 
Mapkinase signaling pathway	4137	PID BIOCARTA	9606	4	56	0.01824154474181903	0.0414691117130686	CEBPA; JUN; MAP3K7; SP1; 	CEBPA|IDBG-409028|ENSG00000245848|1050|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SP1|IDBG-36616|ENSG00000185591|6667|; 
MAPK signaling pathway	487	KEGG	9606	10	257	0.018129151815633536	0.041490206504235135	AKT2; CACNB3; EGFR; JUN; KRAS; MAP3K7; MAPT; PPM1A; TAB1; TAB2; 	AKT2|IDBG-51270|ENSG00000105221|208|; CACNB3|IDBG-30418|ENSG00000167535|784|; EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; MAPT|IDBG-55163|ENSG00000186868|4137|; PPM1A|IDBG-8210|ENSG00000100614|5494|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
Carm1 and regulation of the estrogen receptor	4134	PID BIOCARTA	9606	2	12	0.019021175972542315	0.0419820129879413	EP300; ESR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; 
Downregulation of ERBB2:ERBB3 signaling	13285	REACTOME	9606	2	12	0.019021175972542315	0.0419820129879413	AKT2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; UBC|IDBG-64029|ENSG00000150991|7316|; 
HSF1 activation	19458	REACTOME	9606	2	12	0.019021175972542315	0.0419820129879413	EEF1A1; YWHAE; 	EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Il 3 signaling pathway	3967	PID BIOCARTA	9606	2	12	0.019021175972542315	0.0419820129879413	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Inhibition of replication initiation of damaged DNA by RB1/E2F1	12966	REACTOME	9606	2	12	0.019021175972542315	0.0419820129879413	PRIM1; PRIM2; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
JNK signaling in the CD4+ TCR pathway	15461	PID NCI	9606	2	12	0.019021175972542315	0.0419820129879413	JUN; MAP3K7; 	JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
p38MAPK events	13182	REACTOME	9606	2	12	0.019021175972542315	0.0419820129879413	KRAS; RALB; 	KRAS|IDBG-23889|ENSG00000133703|3845|; RALB|IDBG-68212|ENSG00000144118|5899|; 
ErbB1 downstream signaling	15233	PID NCI	9606	5	85	0.018676596341375255	0.04217694935370174	ACTR3; EGFR; JUN; SRC; YWHAZ; 	ACTR3|IDBG-67369|ENSG00000115091|10096|; EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
PDGFR-beta signaling pathway	15816	PID NCI	9606	5	85	0.018676596341375255	0.04217694935370174	ACTR3; JAK2; JUN; PIN1; SHC1; 	ACTR3|IDBG-67369|ENSG00000115091|10096|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; PIN1|IDBG-26087|ENSG00000127445|5300|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
NOD-like receptor signaling pathway	8112	KEGG	9606	4	57	0.019349244110898747	0.04256833704397724	ERBB2IP; MAP3K7; TAB1; TAB2; 	ERBB2IP|IDBG-24405|ENSG00000112851|55914|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
EPHB forward signaling	15316	PID NCI	9606	3	32	0.019586740331758012	0.04281460546877873	EPHB3; SHC1; SRC; 	EPHB3|IDBG-68339|ENSG00000182580|2049|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Role of egf receptor transactivation by gpcrs in cardiac hypertrophy	3987	PID BIOCARTA	9606	3	32	0.019586740331758012	0.04281460546877873	EGFR; JUN; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Metabolism of proteins	18366	REACTOME	9606	20	678	0.020241487681540906	0.044104455587255266	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; EEF1A1; EEF1A2; EIF1AX; EIF2AK3; EIF2B2; EIF5; EIF5A; EIF5B; FBXO6; HSCB; RPS4Y1; SHC1; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; EEF1A2|IDBG-86175|ENSG00000101210|1917|; EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF2AK3|IDBG-60518|ENSG00000172071|9451|; EIF2B2|IDBG-12676|ENSG00000119718|8892|; EIF5|IDBG-21484|ENSG00000100664|1983|; EIF5A|IDBG-24314|ENSG00000132507|1984|; EIF5B|IDBG-63343|ENSG00000158417|9669|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HSCB|IDBG-3404|ENSG00000100209|150274|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; SHC1|IDBG-103007|ENSG00000160691|6464|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Acute myeloid leukemia	424	KEGG	9606	4	58	0.02049771867598265	0.04452052272936359	AKT2; CEBPA; KRAS; SPI1; 	AKT2|IDBG-51270|ENSG00000105221|208|; CEBPA|IDBG-409028|ENSG00000245848|1050|; KRAS|IDBG-23889|ENSG00000133703|3845|; SPI1|IDBG-43260|ENSG00000066336|6688|; 
Bioactive peptide induced signaling pathway	4135	PID BIOCARTA	9606	3	33	0.021265548471942338	0.04560724546498326	JAK2; MAPT; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; MAPT|IDBG-55163|ENSG00000186868|4137|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
E2F mediated regulation of DNA replication	12968	REACTOME	9606	3	33	0.021265548471942338	0.04560724546498326	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Integrin signaling pathway	4024	PID BIOCARTA	9606	3	33	0.021265548471942338	0.04560724546498326	ACTA1; SHC1; SRC; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Negative regulators of RIG-I/MDA5 signaling	13013	REACTOME	9606	3	33	0.021265548471942338	0.04560724546498326	CYLD; PIN1; UBC; 	CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; PIN1|IDBG-26087|ENSG00000127445|5300|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IL5	15921	NETPATH	9606	4	59	0.02168732767860141	0.04636601089907887	JAK2; JUN; SHC1; YWHAZ; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Il 6 signaling pathway	3992	PID BIOCARTA	9606	2	13	0.022215722113509445	0.04705317540811627	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling by Activin	13273	REACTOME	9606	2	13	0.022215722113509445	0.04705317540811627	SMAD2; SMAD3; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
repression of WNT target genes	18872	REACTOME	9606	2	13	0.022215722113509445	0.04705317540811627	TLE1; TLE2; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; 
Coregulation of Androgen receptor activity	15082	PID NCI	9606	4	60	0.022918403958548376	0.04839118111371515	AR; NCOA2; NCOA6; UBE3A; 	AR|IDBG-73722|ENSG00000169083|367|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; UBE3A|IDBG-4274|ENSG00000114062|7337|; 
Gap junction	436	KEGG	9606	5	90	0.023302385480815212	0.0488991596858953	EGFR; KRAS; SRC; TUBA4A; TUBB8; 	EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; SRC|IDBG-74081|ENSG00000197122|6714|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; TUBB8|IDBG-777287|ENSG00000261456|347688|; 
Prostate cancer	544	KEGG	9606	5	90	0.023302385480815212	0.0488991596858953	AKT2; AR; EGFR; EP300; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; AR|IDBG-73722|ENSG00000169083|367|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Interferon Signaling	18059	REACTOME	9606	7	158	0.024393797363320164	0.05103242270485997	ARIH1; ICAM1; JAK2; KPNB1; NEDD4; PIN1; UBC; 	ARIH1|IDBG-20750|ENSG00000166233|25820|; ICAM1|IDBG-26804|ENSG00000090339|3383|; JAK2|IDBG-47039|ENSG00000096968|3717|; KPNB1|IDBG-56053|ENSG00000108424|3837|; NEDD4|IDBG-13236|ENSG00000069869|4734|; PIN1|IDBG-26087|ENSG00000127445|5300|; UBC|IDBG-64029|ENSG00000150991|7316|; 
HGF signaling pathway	16200	INOH	9606	3	35	0.024852570068144366	0.0515180935759102	KRAS; SHC1; SRC; 	KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Validated transcriptional targets of AP1 family members Fra1 and Fra2	14994	PID NCI	9606	3	35	0.024852570068144366	0.0515180935759102	EP300; JUN; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; JUN|IDBG-99221|ENSG00000177606|3725|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Adaptive Immune System	18371	REACTOME	9606	18	604	0.024740431622739693	0.051599309989934165	AKT2; CD81; CUL3; DYNLL1; DZIP3; EGFR; FBXO6; HUWE1; ICAM1; KRAS; MAP3K7; NEDD4; TAB2; TUBA4A; UBC; UBE3A; VHL; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CD81|IDBG-22455|ENSG00000110651|975|; CUL3|IDBG-82331|ENSG00000036257|8452|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; DZIP3|IDBG-49039|ENSG00000198919|9666|; EGFR|IDBG-16933|ENSG00000146648|1956|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HUWE1|IDBG-70116|ENSG00000086758|10075|; ICAM1|IDBG-26804|ENSG00000090339|3383|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NEDD4|IDBG-13236|ENSG00000069869|4734|; TAB2|IDBG-97690|ENSG00000055208|23118|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Attenuation phase	17488	REACTOME	9606	2	14	0.02561458478555754	0.052776878621601936	DNAJB1; EP300; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; EP300|IDBG-8992|ENSG00000100393|2033|; 
S1P3 pathway	15477	PID NCI	9606	2	14	0.02561458478555754	0.052776878621601936	JAK2; SRC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SRC|IDBG-74081|ENSG00000197122|6714|; 
BCR signaling pathway	15384	PID NCI	9606	4	63	0.02686337206573666	0.054526249252477385	CSNK2A1; JUN; MAP3K7; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Meiotic recombination	13921	REACTOME	9606	4	63	0.02686337206573666	0.054526249252477385	HIST2H2AC; HIST2H2BE; HIST3H3; RAD51; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; RAD51|IDBG-6509|ENSG00000051180|5888|; 
IGF1 signaling pathway	16216	INOH	9606	3	36	0.02676070777586563	0.0546431218656897	AKT2; KRAS; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Role of Calcineurin-dependent NFAT signaling in lymphocytes	15595	PID NCI	9606	3	36	0.02676070777586563	0.0546431218656897	CSNK2A1; KPNB1; YWHAQ; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; KPNB1|IDBG-56053|ENSG00000108424|3837|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Signaling events regulated by Ret tyrosine kinase	15569	PID NCI	9606	3	36	0.02676070777586563	0.0546431218656897	JUN; SHC1; SRC; 	JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
E2F transcription factor network	15410	PID NCI	9606	4	64	0.028263123477869374	0.05719718163770597	CEBPA; E2F7; SIRT1; SP1; 	CEBPA|IDBG-409028|ENSG00000245848|1050|; E2F7|IDBG-49113|ENSG00000165891|144455|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Association of licensing factors with the pre-replicative complex	12933	REACTOME	9606	2	15	0.02920942693262282	0.05757465077470741	GMNN; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Canonical Wnt signaling pathway	15524	PID NCI	9606	2	15	0.02920942693262282	0.05757465077470741	CUL3; LRP6; 	CUL3|IDBG-82331|ENSG00000036257|8452|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
Estrogen responsive protein efp controls cell cycle and breast tumors growth	4072	PID BIOCARTA	9606	2	15	0.02920942693262282	0.05757465077470741	CCNB2; ESR1; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; ESR1|IDBG-97997|ENSG00000091831|2099|; 
Gamma-aminobutyric acid receptor life cycle pathway	3986	PID BIOCARTA	9606	2	15	0.02920942693262282	0.05757465077470741	SRC; UBE3A; 	SRC|IDBG-74081|ENSG00000197122|6714|; UBE3A|IDBG-4274|ENSG00000114062|7337|; 
Mechanisms of transcriptional repression by dna methylation	3966	PID BIOCARTA	9606	2	15	0.02920942693262282	0.05757465077470741	CHD3; CHD4; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; 
Telomeres telomerase cellular aging and immortality	4017	PID BIOCARTA	9606	2	15	0.02920942693262282	0.05757465077470741	KRAS; TERF1; 	KRAS|IDBG-23889|ENSG00000133703|3845|; TERF1|IDBG-25349|ENSG00000147601|7013|; 
negative regulation of TCF-dependent signaling by WNT ligand antagonists	18430	REACTOME	9606	2	15	0.02920942693262282	0.05757465077470741	LRP5; LRP6; 	LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
ATR signaling pathway	15654	PID NCI	9606	3	37	0.028745078333036432	0.058000424328789484	MCM2; RAD51; YWHAZ; 	MCM2|IDBG-54871|ENSG00000073111|4171|; RAD51|IDBG-6509|ENSG00000051180|5888|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Signaling by EGFR	13216	REACTOME	9606	7	164	0.02912335468837023	0.05859034778014306	AKT2; EGFR; HGS; JAK2; KRAS; SHC1; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; HGS|IDBG-72504|ENSG00000185359|9146|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by EGFR in Cancer	16839	REACTOME	9606	7	166	0.030828806860774292	0.06024425867922083	AKT2; EGFR; HGS; JAK2; KRAS; SHC1; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; HGS|IDBG-72504|ENSG00000185359|9146|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Synthesis of DNA	16950	REACTOME	9606	5	97	0.03093395816579527	0.0602770270544925	MCM2; PCNA; PRIM1; PRIM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
FOXA2 and FOXA3 transcription factor networks	14900	PID NCI	9606	3	38	0.030805447822511958	0.060371596019980336	FOXA1; HNF4A; SP1; 	FOXA1|IDBG-5104|ENSG00000129514|3169|; HNF4A|IDBG-76498|ENSG00000101076|3172|; SP1|IDBG-36616|ENSG00000185591|6667|; 
ID	15909	NETPATH	9606	3	38	0.030805447822511958	0.060371596019980336	OLIG2; SMAD3; TCF12; 	OLIG2|IDBG-1917|ENSG00000205927|10215|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TCF12|IDBG-13567|ENSG00000140262|6938|; 
Glioma	523	KEGG	9606	4	66	0.031191029179601683	0.06060479173928304	AKT2; EGFR; KRAS; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
CRMPs in Sema3A signaling	13906	REACTOME	9606	2	16	0.032992143044445386	0.06302700716053712	DPYSL2; DPYSL5; 	DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; 
Glypican 1 network	15119	PID NCI	9606	2	16	0.032992143044445386	0.06302700716053712	APP; SMAD2; 	APP|IDBG-1100|ENSG00000142192|351|; SMAD2|IDBG-3127|ENSG00000175387|4087|; 
Il12 and stat4 dependent signaling pathway in th1 development	4054	PID BIOCARTA	9606	2	16	0.032992143044445386	0.06302700716053712	JAK2; JUN; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; 
Polo-like kinase mediated events	12971	REACTOME	9606	2	16	0.032992143044445386	0.06302700716053712	CCNB2; EP300; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; EP300|IDBG-8992|ENSG00000100393|2033|; 
RAF/MAP kinase cascade	17797	REACTOME	9606	2	16	0.032992143044445386	0.06302700716053712	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
EPHB-mediated forward signaling	17191	REACTOME	9606	3	39	0.032941510733558936	0.06382417704627044	ACTG1; ACTR3; EPHB3; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ACTR3|IDBG-67369|ENSG00000115091|10096|; EPHB3|IDBG-68339|ENSG00000182580|2049|; 
Membrane Trafficking	19875	REACTOME	9606	8	207	0.03405617177277191	0.06487795851684482	ACTG1; AKT2; HGS; TUBA4A; UBC; YWHAE; YWHAQ; YWHAZ; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; AKT2|IDBG-51270|ENSG00000105221|208|; HGS|IDBG-72504|ENSG00000185359|9146|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Glucocorticoid receptor regulatory network	15321	PID NCI	9606	4	69	0.0359062000650909	0.06821177839663507	ICAM1; JUN; NCOA2; SPI1; 	ICAM1|IDBG-26804|ENSG00000090339|3383|; JUN|IDBG-99221|ENSG00000177606|3725|; NCOA2|IDBG-24827|ENSG00000140396|10499|; SPI1|IDBG-43260|ENSG00000066336|6688|; 
E-cadherin signaling in keratinocytes	15730	PID NCI	9606	2	17	0.03695485359608339	0.06904989082884622	EGFR; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SRC|IDBG-74081|ENSG00000197122|6714|; 
EPHA2 forward signaling	15662	PID NCI	9606	2	17	0.03695485359608339	0.06904989082884622	SHC1; SRC; 	SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Syndecan-3-mediated signaling events	15336	PID NCI	9606	2	17	0.03695485359608339	0.06904989082884622	EGFR; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Tie2 Signaling	13110	REACTOME	9606	2	17	0.03695485359608339	0.06904989082884622	KRAS; SHC1; 	KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Ucalpain and friends in cell spread	3968	PID BIOCARTA	9606	2	17	0.03695485359608339	0.06904989082884622	ACTA1; SRC; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Mitotic G1-G1/S phases	17361	REACTOME	9606	6	136	0.03662060729998578	0.06937570605163973	DBF4; MCM2; PCNA; PRIM1; PRIM2; UBC; 	DBF4|IDBG-25283|ENSG00000006634|10926|; MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Recycling pathway of L1	13874	REACTOME	9606	3	41	0.03743915830944107	0.06976367750557053	ACTG1; DPYSL2; TUBA4A; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Antigen processing: Ubiquitination & Proteasome degradation	12981	REACTOME	9606	8	212	0.03838363094850238	0.07132870928304802	CUL3; DZIP3; FBXO6; HUWE1; NEDD4; UBC; UBE3A; VHL; 	CUL3|IDBG-82331|ENSG00000036257|8452|; DZIP3|IDBG-49039|ENSG00000198919|9666|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HUWE1|IDBG-70116|ENSG00000086758|10075|; NEDD4|IDBG-13236|ENSG00000069869|4734|; UBC|IDBG-64029|ENSG00000150991|7316|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Toll-like receptor signaling pathway	564	KEGG	9606	5	103	0.03859550794531043	0.07152754461603726	AKT2; JUN; MAP3K7; TAB1; TAB2; 	AKT2|IDBG-51270|ENSG00000105221|208|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
KitReceptor	15910	NETPATH	9606	5	104	0.039975455842574704	0.07388417583912181	EP300; JAK2; JUN; SHC1; SRC; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Axon guidance	17789	REACTOME	9606	11	336	0.04114081105957221	0.07502147899098462	ACTG1; ACTR3; CACNB3; CSNK2A1; DPYSL2; DPYSL5; EGFR; EPHB3; JAK2; KRAS; TUBA4A; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ACTR3|IDBG-67369|ENSG00000115091|10096|; CACNB3|IDBG-30418|ENSG00000167535|784|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; EGFR|IDBG-16933|ENSG00000146648|1956|; EPHB3|IDBG-68339|ENSG00000182580|2049|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Ubiquitin mediated proteolysis	519	KEGG	9606	6	140	0.041259621086158785	0.07503749754869411	CUL3; CUL4A; HUWE1; NEDD4; UBE3A; VHL; 	CUL3|IDBG-82331|ENSG00000036257|8452|; CUL4A|IDBG-52956|ENSG00000139842|8451|; HUWE1|IDBG-70116|ENSG00000086758|10075|; NEDD4|IDBG-13236|ENSG00000069869|4734|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Atm signaling pathway	3932	PID BIOCARTA	9606	2	18	0.04108989959691704	0.0751295215150065	JUN; RAD51; 	JUN|IDBG-99221|ENSG00000177606|3725|; RAD51|IDBG-6509|ENSG00000051180|5888|; 
Mets affect on macrophage differentiation	4075	PID BIOCARTA	9606	2	18	0.04108989959691704	0.0751295215150065	JUN; NCOR2; 	JUN|IDBG-99221|ENSG00000177606|3725|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	13922	REACTOME	9606	2	18	0.04108989959691704	0.0751295215150065	UBC; VHL; 	UBC|IDBG-64029|ENSG00000150991|7316|; VHL|IDBG-17819|ENSG00000134086|7428|; 
p38 MAPK signaling pathway	15901	PID NCI	9606	2	18	0.04108989959691704	0.0751295215150065	MAP3K7; TAB2; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
G2/M Checkpoints	17760	REACTOME	9606	3	43	0.04223427887734689	0.07660579307008132	CCNB2; DBF4; MCM2; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; DBF4|IDBG-25283|ENSG00000006634|10926|; MCM2|IDBG-54871|ENSG00000073111|4171|; 
Organelle biogenesis and maintenance	16766	REACTOME	9606	6	142	0.04371242493178464	0.07907658833813562	HDAC3; NCOA2; NCOA6; NCOR1; TBL1X; TBL1XR1; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Downstream TCR signaling	13068	REACTOME	9606	3	44	0.04474196572042597	0.07946359536804821	MAP3K7; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
SHP2 signaling	15583	PID NCI	9606	3	44	0.04474196572042597	0.07946359536804821	EGFR; JAK2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
SIRT1 negatively regulates rRNA Expression	17988	REACTOME	9606	3	44	0.04474196572042597	0.07946359536804821	HIST2H2AC; HIST2H2BE; SIRT1; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; SIRT1|IDBG-75847|ENSG00000096717|23411|; 
Signaling by Insulin receptor	13281	REACTOME	9606	5	107	0.044294070592999134	0.07991681519689262	AKT2; JAK2; KRAS; PPM1A; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
IL-7 signaling	16106	INOH	9606	7	180	0.04466479387262848	0.07995115333630609	AKT2; CSNK1E; EGFR; JAK2; MAP3K7; SRC; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Downregulated of mta-3 in er-negative breast tumors	3959	PID BIOCARTA	9606	2	19	0.045389837275842594	0.07998932563856499	ESR1; TUBA4A; 	ESR1|IDBG-97997|ENSG00000091831|2099|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
SOS-mediated signalling	13209	REACTOME	9606	2	19	0.045389837275842594	0.07998932563856499	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Signaling by NODAL	13884	REACTOME	9606	2	19	0.045389837275842594	0.07998932563856499	SMAD2; SMAD3; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
B cell receptor signaling pathway	532	KEGG	9606	4	74	0.04463280301540731	0.08010413593817839	AKT2; CD81; JUN; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; CD81|IDBG-22455|ENSG00000110651|975|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Chronic myeloid leukemia	582	KEGG	9606	4	74	0.04463280301540731	0.08010413593817839	AKT2; KRAS; SHC1; SMAD3; 	AKT2|IDBG-51270|ENSG00000105221|208|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
EPO signaling pathway	16151	INOH	9606	7	181	0.0457842199684461	0.08047638664556764	AKT2; CSNK1E; EGFR; JAK2; MAP3K7; SRC; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SRC|IDBG-74081|ENSG00000197122|6714|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
L1CAM interactions	13877	REACTOME	9606	5	109	0.047322890160660575	0.08254273935951538	ACTG1; CSNK2A1; DPYSL2; EGFR; TUBA4A; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; EGFR|IDBG-16933|ENSG00000146648|1956|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Interleukin-2 signaling	13083	REACTOME	9606	3	45	0.047322202651442845	0.08275318514944621	JAK2; KRAS; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Posttranslational regulation of adherens junction stability and dissassembly	15876	PID NCI	9606	3	45	0.047322202651442845	0.08275318514944621	EGFR; HGS; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; HGS|IDBG-72504|ENSG00000185359|9146|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Innate Immune System	17476	REACTOME	9606	16	563	0.048002832210541024	0.0835151315499719	ACTG1; ACTR3; AKT2; APP; CYLD; EGFR; EP300; JAK2; JUN; KRAS; MAP3K7; NCKIPSD; PIN1; TAB1; TAB2; UBC; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ACTR3|IDBG-67369|ENSG00000115091|10096|; AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NCKIPSD|IDBG-239383|ENSG00000213672|51517|; PIN1|IDBG-26087|ENSG00000127445|5300|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IRS-mediated signalling	18112	REACTOME	9606	4	76	0.04842764955803191	0.08403983969103757	AKT2; JAK2; KRAS; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Egf signaling pathway	4162	PID BIOCARTA	9606	2	20	0.04984743287315448	0.0856321139030009	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Lissencephaly gene (lis1) in neuronal migration and development	3976	PID BIOCARTA	9606	2	20	0.04984743287315448	0.0856321139030009	CSNK2A1; DYNLL1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DYNLL1|IDBG-60661|ENSG00000088986|8655|; 
Nf-kb signaling pathway	3978	PID BIOCARTA	9606	2	20	0.04984743287315448	0.0856321139030009	MAP3K7; TAB1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Signal transduction by L1	13872	REACTOME	9606	2	20	0.04984743287315448	0.0856321139030009	CSNK2A1; EGFR; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Cap-dependent Translation Initiation	18804	REACTOME	9606	5	112	0.05209180432248478	0.08903912418028727	EIF1AX; EIF2B2; EIF5; EIF5B; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF2B2|IDBG-12676|ENSG00000119718|8892|; EIF5|IDBG-21484|ENSG00000100664|1983|; EIF5B|IDBG-63343|ENSG00000158417|9669|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Eukaryotic Translation Initiation	16696	REACTOME	9606	5	112	0.05209180432248478	0.08903912418028727	EIF1AX; EIF2B2; EIF5; EIF5B; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF2B2|IDBG-12676|ENSG00000119718|8892|; EIF5|IDBG-21484|ENSG00000100664|1983|; EIF5B|IDBG-63343|ENSG00000158417|9669|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
G beta:gamma signalling through PI3Kgamma	13221	REACTOME	9606	3	47	0.05269743071558821	0.0898491193700779	AKT2; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Growth hormone signaling pathway	4113	PID BIOCARTA	9606	2	21	0.05445565755696787	0.09170063815765948	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
NGF signaling pathway	16214	INOH	9606	2	21	0.05445565755696787	0.09170063815765948	KRAS; SHC1; 	KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signalling to p38 via RIT and RIN	13183	REACTOME	9606	2	21	0.05445565755696787	0.09170063815765948	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
CD4 T cell receptor signaling	16104	INOH	9606	4	79	0.0544445006431311	0.09236604337964031	AKT2; JUN; KRAS; MAP3K7; 	AKT2|IDBG-51270|ENSG00000105221|208|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
IRS-related events	18844	REACTOME	9606	4	79	0.0544445006431311	0.09236604337964031	AKT2; JAK2; KRAS; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
HATs acetylate histones	16644	REACTOME	9606	5	114	0.055421864088857874	0.09286906955430238	EP300; HIST2H2AC; HIST2H2BE; MBIP; WDR5; 	EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; MBIP|IDBG-4937|ENSG00000151332|51562|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Oocyte meiosis	8113	KEGG	9606	5	114	0.055421864088857874	0.09286906955430238	AR; CCNB2; YWHAE; YWHAQ; YWHAZ; 	AR|IDBG-73722|ENSG00000169083|367|; CCNB2|IDBG-14456|ENSG00000157456|9133|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
IRS-related events triggered by IGF1R	13282	REACTOME	9606	4	80	0.05653622612939347	0.0942731203429006	AKT2; JAK2; KRAS; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
TGF-beta signaling pathway	465	KEGG	9606	4	80	0.05653622612939347	0.0942731203429006	EP300; SMAD2; SMAD3; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Signalling by NGF	16818	REACTOME	9606	9	271	0.05714335428119472	0.09505309175554828	AKT2; EGFR; HDAC3; JAK2; KRAS; RALB; SHC1; UBC; YWHAE; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; HDAC3|IDBG-50725|ENSG00000171720|8841|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Condensation of Prophase Chromosomes	17113	REACTOME	9606	3	49	0.05835372676196069	0.09636135993137333	HIST2H2AC; HIST2H2BE; HIST3H3; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; 
FCERI mediated MAPK activation	19852	REACTOME	9606	3	49	0.05835372676196069	0.09636135993137333	JAK2; JUN; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
PRC2 methylates histones and DNA	16775	REACTOME	9606	3	49	0.05835372676196069	0.09636135993137333	HIST2H2AC; HIST2H2BE; SUZ12; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; SUZ12|IDBG-39777|ENSG00000178691|23512|; 
ARMS-mediated activation	13181	REACTOME	9606	2	22	0.059207682446165553	0.09660200820163853	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Erk1/erk2 mapk signaling pathway	4174	PID BIOCARTA	9606	2	22	0.059207682446165553	0.09660200820163853	SHC1; SRC; 	SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
HSF1-dependent transactivation	18731	REACTOME	9606	2	22	0.059207682446165553	0.09660200820163853	DNAJB1; EP300; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; EP300|IDBG-8992|ENSG00000100393|2033|; 
Inhibition of cellular proliferation by gleevec	3946	PID BIOCARTA	9606	2	22	0.059207682446165553	0.09660200820163853	JAK2; JUN; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; 
Transport of Mature mRNA derived from an Intron-Containing Transcript	13747	REACTOME	9606	2	22	0.059207682446165553	0.09660200820163853	SRSF3; SRSF9; 	SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
CXCR4-mediated signaling events	15059	PID NCI	9606	3	50	0.0612851459307433	0.09904376664636713	HGS; JAK2; RALB; 	HGS|IDBG-72504|ENSG00000185359|9146|; JAK2|IDBG-47039|ENSG00000096968|3717|; RALB|IDBG-68212|ENSG00000144118|5899|; 
G-protein beta:gamma signalling	17727	REACTOME	9606	3	50	0.0612851459307433	0.09904376664636713	AKT2; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
GPVI-mediated activation cascade	13127	REACTOME	9606	3	50	0.0612851459307433	0.09904376664636713	AKT2; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling events mediated by focal adhesion kinase	15260	PID NCI	9606	3	50	0.0612851459307433	0.09904376664636713	ACTA1; JUN; SRC; 	ACTA1|IDBG-107311|ENSG00000143632|58|; JUN|IDBG-99221|ENSG00000177606|3725|; SRC|IDBG-74081|ENSG00000197122|6714|; 
FGF signaling pathway	15346	PID NCI	9606	3	51	0.06428420244624694	0.10243417305687012	JUN; SHC1; SRC; 	JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
How progesterone initiates the oocyte maturation	4077	PID BIOCARTA	9606	2	23	0.06409687374810083	0.10261518285494077	PIN1; SRC; 	PIN1|IDBG-26087|ENSG00000127445|5300|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Methionine Cysteine metabolism	16250	INOH	9606	2	23	0.06409687374810083	0.10261518285494077	AHCYL1; AHCYL2; 	AHCYL1|IDBG-100935|ENSG00000168710|10768|; AHCYL2|IDBG-40716|ENSG00000158467|23382|; 
Segmentation clock	3960	PID BIOCARTA	9606	2	23	0.06409687374810083	0.10261518285494077	CSNK2A1; LRP6; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
Signaling by Leptin	19841	REACTOME	9606	2	23	0.06409687374810083	0.10261518285494077	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Toxoplasmosis	10385	KEGG	9606	5	119	0.0642746466698939	0.10265880334629424	AKT2; JAK2; MAP3K7; TAB1; TAB2; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TAB2|IDBG-97690|ENSG00000055208|23118|; 
RNA Polymerase I Promoter Clearance	17889	REACTOME	9606	4	84	0.06532938584069181	0.10361544451942283	CHD3; CHD4; HIST2H2AC; HIST2H2BE; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Senescence-Associated Secretory Phenotype (SASP)	19271	REACTOME	9606	4	84	0.06532938584069181	0.10361544451942283	HIST2H2AC; HIST2H2BE; JUN; UBC; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; JUN|IDBG-99221|ENSG00000177606|3725|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Mitotic Prometaphase	12940	REACTOME	9606	5	120	0.06613542507064793	0.1046504870027422	CCNB2; CSNK2A1; MIS12; NUDC; TUBA4A; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; MIS12|IDBG-21731|ENSG00000167842|79003|; NUDC|IDBG-94765|ENSG00000090273|10726|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
B cell receptor signaling	16132	INOH	9606	3	52	0.06734994640529957	0.10632560983429237	KRAS; MAP3K7; SRC; 	KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Neurotrophin signaling pathway	4379	KEGG	9606	5	121	0.0680261605253189	0.1071451304347979	AKT2; JUN; KRAS; SHC1; YWHAE; 	AKT2|IDBG-51270|ENSG00000105221|208|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
M Phase	18628	REACTOME	9606	9	281	0.06850017774448862	0.10764313645562497	CCNB2; CSNK2A1; HIST2H2AC; HIST2H2BE; HIST3H3; MIS12; NUDC; TUBA4A; UBC; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; MIS12|IDBG-21731|ENSG00000167842|79003|; NUDC|IDBG-94765|ENSG00000090273|10726|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Frs2-mediated activation	13180	REACTOME	9606	2	24	0.06911678800954366	0.10811387482226784	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
a6b1 and a6b4 Integrin signaling	15252	PID NCI	9606	2	24	0.06911678800954366	0.10811387482226784	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
RNA Polymerase I Transcription	16984	REACTOME	9606	4	86	0.0699788221827447	0.10921180029435215	CHD3; CHD4; HIST2H2AC; HIST2H2BE; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Caspase Cascade in Apoptosis	14995	PID NCI	9606	3	53	0.07048139676562795	0.10949501729876597	ACTA1; APP; TOP1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; APP|IDBG-1100|ENSG00000142192|351|; TOP1|IDBG-75139|ENSG00000198900|7150|; 
Endometrial cancer	506	KEGG	9606	3	53	0.07048139676562795	0.10949501729876597	AKT2; EGFR; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
TSLP	15928	NETPATH	9606	6	161	0.07155426396229078	0.11090910914155072	CHD8; JAK2; RPAP1; SHC1; SRC; WDR36; 	CHD8|IDBG-2645|ENSG00000100888|57680|; JAK2|IDBG-47039|ENSG00000096968|3717|; RPAP1|IDBG-7174|ENSG00000103932|102724088,26015|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; WDR36|IDBG-36607|ENSG00000134987|134430|; 
Maturity onset diabetes of the young	571	KEGG	9606	2	25	0.074261167461248	0.11406782929858365	HHEX; HNF4A; 	HHEX|IDBG-82541|ENSG00000152804|3087|; HNF4A|IDBG-76498|ENSG00000101076|3172|; 
Signaling events mediated by HDAC Class III	15506	PID NCI	9606	2	25	0.074261167461248	0.11406782929858365	EP300; SIRT1; 	EP300|IDBG-8992|ENSG00000100393|2033|; SIRT1|IDBG-75847|ENSG00000096717|23411|; 
Wnt signaling network	15193	PID NCI	9606	2	25	0.074261167461248	0.11406782929858365	LRP5; LRP6; 	LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
S Phase	17420	REACTOME	9606	5	124	0.07387737670046593	0.11425027417169561	MCM2; PCNA; PRIM1; PRIM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Ribosomal scanning and start codon recognition	13450	REACTOME	9606	3	55	0.07693734979546232	0.11764859318498946	EIF1AX; EIF5; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF5|IDBG-21484|ENSG00000100664|1983|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
p75(NTR)-mediated signaling	15333	PID NCI	9606	3	55	0.07693734979546232	0.11764859318498946	APP; SHC1; YWHAE; 	APP|IDBG-1100|ENSG00000142192|351|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Prolonged ERK activation events	19186	REACTOME	9606	2	26	0.07952393548127232	0.12079136747934906	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Transport of Mature Transcript to Cytoplasm	18637	REACTOME	9606	2	26	0.07952393548127232	0.12079136747934906	SRSF3; SRSF9; 	SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
Trk receptor signaling mediated by PI3K and PLC-gamma	14893	PID NCI	9606	2	26	0.07952393548127232	0.12079136747934906	SHC1; SRC; 	SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Non-small cell lung cancer	444	KEGG	9606	3	57	0.0836436710624408	0.12676663036574362	AKT2; EGFR; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
GnRH signaling pathway	412	KEGG	9606	4	92	0.08491335618581591	0.1272767228982999	EGFR; JUN; KRAS; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Direct p53 effectors	15209	PID NCI	9606	5	129	0.08422037198290566	0.1273576356814671	EGFR; FOXA1; JUN; PCNA; SP1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; FOXA1|IDBG-5104|ENSG00000129514|3169|; JUN|IDBG-99221|ENSG00000177606|3725|; PCNA|IDBG-50801|ENSG00000132646|5111|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Dorso-ventral axis formation	4377	KEGG	9606	2	27	0.0848991921560947	0.12753579086003652	EGFR; KRAS; 	EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Interleukin receptor SHC signaling	13081	REACTOME	9606	2	27	0.0848991921560947	0.12753579086003652	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
mTOR signalling	13277	REACTOME	9606	2	27	0.0848991921560947	0.12753579086003652	AKT2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Endosomal Sorting Complex Required For Transport (ESCRT)	13824	REACTOME	9606	2	28	0.09038120992766746	0.13429190668991112	HGS; UBC; 	HGS|IDBG-72504|ENSG00000185359|9146|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IL2 signaling events mediated by STAT5	15584	PID NCI	9606	2	28	0.09038120992766746	0.13429190668991112	SHC1; SP1; 	SHC1|IDBG-103007|ENSG00000160691|6464|; SP1|IDBG-36616|ENSG00000185591|6667|; 
PKB-mediated events	16929	REACTOME	9606	2	28	0.09038120992766746	0.13429190668991112	AKT2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Thromboxane A2 receptor signaling	14941	PID NCI	9606	2	28	0.09038120992766746	0.13429190668991112	EGFR; ICAM1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
Amyloids	13692	REACTOME	9606	3	59	0.0905916029547724	0.13431189829381474	APP; HIST2H2AC; HIST2H2BE; 	APP|IDBG-1100|ENSG00000142192|351|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Class I MHC mediated antigen processing & presentation	19282	REACTOME	9606	8	256	0.09255136528459698	0.13691980721061853	CUL3; DZIP3; FBXO6; HUWE1; NEDD4; UBC; UBE3A; VHL; 	CUL3|IDBG-82331|ENSG00000036257|8452|; DZIP3|IDBG-49039|ENSG00000198919|9666|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HUWE1|IDBG-70116|ENSG00000086758|10075|; NEDD4|IDBG-13236|ENSG00000069869|4734|; UBC|IDBG-64029|ENSG00000150991|7316|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Endocytosis	4386	KEGG	9606	7	214	0.09301794310805842	0.13731220173094338	EGFR; HGS; NEDD4; RABEP1; SMAD2; SMAD3; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; HGS|IDBG-72504|ENSG00000185359|9146|; NEDD4|IDBG-13236|ENSG00000069869|4734|; RABEP1|IDBG-21268|ENSG00000029725|9135|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Signaling events mediated by VEGFR1 and VEGFR2	15504	PID NCI	9606	3	60	0.0941533502717313	0.13838919156319127	HGS; NEDD4; SRC; 	HGS|IDBG-72504|ENSG00000185359|9146|; NEDD4|IDBG-13236|ENSG00000069869|4734|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Signal Transduction	17980	REACTOME	9606	43	1965	0.09409196554472184	0.13859766846976304	ACTG1; AKT2; APP; CHD8; CSNK1E; CSNK2A1; CUL3; EGFR; EP300; ERBB2IP; ESR1; HDAC3; HGS; HIST2H2AC; HIST2H2BE; HIST3H3; HTR7; JAK2; JUN; KRAS; LRP5; LRP6; MAP3K7; NCOR1; NCOR2; NEDD4; PPM1A; RALB; SHC1; SMAD2; SMAD3; SP1; SRC; TAB2; TBL1X; TBL1XR1; TLE1; TLE2; TUBA4A; UBC; WWOX; YWHAE; YWHAZ; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ERBB2IP|IDBG-24405|ENSG00000112851|55914|; ESR1|IDBG-97997|ENSG00000091831|2099|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HGS|IDBG-72504|ENSG00000185359|9146|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; HTR7|IDBG-82120|ENSG00000148680|3363|; JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; NEDD4|IDBG-13236|ENSG00000069869|4734|; PPM1A|IDBG-8210|ENSG00000100614|5494|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SRC|IDBG-74081|ENSG00000197122|6714|; TAB2|IDBG-97690|ENSG00000055208|23118|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; WWOX|IDBG-43129|ENSG00000186153|51741|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Fc epsilon receptor i signaling in mast cells	4183	PID BIOCARTA	9606	2	29	0.09596442936972167	0.14044579577285446	JUN; SHC1; 	JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
The information processing pathway at the ifn beta enhancer	3944	PID BIOCARTA	9606	2	29	0.09596442936972167	0.14044579577285446	JUN; SMARCB1; 	JUN|IDBG-99221|ENSG00000177606|3725|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; 
TCR signaling	17097	REACTOME	9606	3	61	0.09777207938176896	0.14247982508197954	MAP3K7; TAB2; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB2|IDBG-97690|ENSG00000055208|23118|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Tight junction	522	KEGG	9606	5	135	0.09758744841737466	0.14251528869518096	ACTG1; AKT2; CSNK2A1; KRAS; SRC; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; AKT2|IDBG-51270|ENSG00000105221|208|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; KRAS|IDBG-23889|ENSG00000133703|3845|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Hepatitis C	10404	KEGG	9606	5	136	0.09991442708707302	0.1452913417342938	AKT2; CD81; EGFR; EIF2AK3; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; CD81|IDBG-22455|ENSG00000110651|975|; EGFR|IDBG-16933|ENSG00000146648|1956|; EIF2AK3|IDBG-60518|ENSG00000172071|9451|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
BMP receptor signaling	15033	PID NCI	9606	2	30	0.101643455017231	0.14593860278263482	MAP3K7; PPM1A; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Circadian rhythm	526	KEGG	9606	2	30	0.101643455017231	0.14593860278263482	CRY2; CSNK1E; 	CRY2|IDBG-41167|ENSG00000121671|1408|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; 
EPO signaling pathway	15297	PID NCI	9606	2	30	0.101643455017231	0.14593860278263482	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Oncogene Induced Senescence	16811	REACTOME	9606	2	30	0.101643455017231	0.14593860278263482	SP1; UBC; 	SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Pre-NOTCH Transcription and Translation	13300	REACTOME	9606	2	30	0.101643455017231	0.14593860278263482	EP300; JUN; 	EP300|IDBG-8992|ENSG00000100393|2033|; JUN|IDBG-99221|ENSG00000177606|3725|; 
VEGF signaling pathway	432	KEGG	9606	3	62	0.10144661772746157	0.1472055176385719	AKT2; KRAS; SRC; 	AKT2|IDBG-51270|ENSG00000105221|208|; KRAS|IDBG-23889|ENSG00000133703|3845|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Erk and pi-3 kinase are necessary for collagen binding in corneal epithelia	4125	PID BIOCARTA	9606	2	31	0.10741305133219828	0.15261604376783172	ACTA1; SRC; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SRC|IDBG-74081|ENSG00000197122|6714|; 
RhoA signaling pathway	15635	PID NCI	9606	2	31	0.10741305133219828	0.15261604376783172	ACTA1; JUN; 	ACTA1|IDBG-107311|ENSG00000143632|58|; JUN|IDBG-99221|ENSG00000177606|3725|; 
Signaling mediated by p38-alpha and p38-beta	15526	PID NCI	9606	2	31	0.10741305133219828	0.15261604376783172	ESR1; JUN; 	ESR1|IDBG-97997|ENSG00000091831|2099|; JUN|IDBG-99221|ENSG00000177606|3725|; 
VEGFR2 mediated cell proliferation	18519	REACTOME	9606	2	31	0.10741305133219828	0.15261604376783172	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
disassembly of the destruction complex and recruitment of AXIN to the membrane	17567	REACTOME	9606	2	31	0.10741305133219828	0.15261604376783172	LRP5; LRP6; 	LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
Epigenetic regulation of gene expression	17815	REACTOME	9606	4	101	0.1099582725524105	0.15590757147763817	HIST2H2AC; HIST2H2BE; SIRT1; SUZ12; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SUZ12|IDBG-39777|ENSG00000178691|23512|; 
Phospholipids as signalling intermediaries	3981	PID BIOCARTA	9606	2	32	0.11326813873229906	0.15960510457733051	SHC1; SRC; 	SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Signaling by NOTCH2	18259	REACTOME	9606	2	32	0.11326813873229906	0.15960510457733051	EP300; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; 
mRNA 3'-end processing	13667	REACTOME	9606	2	32	0.11326813873229906	0.15960510457733051	SRSF3; SRSF9; 	SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
VEGF signaling pathway	16190	INOH	9606	6	183	0.11405833215806295	0.16038718047793593	AKT2; CSNK1E; EGFR; JAK2; MAP3K7; SRC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Chagas disease (American trypanosomiasis)	10366	KEGG	9606	4	103	0.11592941157857037	0.16268283682424894	AKT2; JUN; SMAD2; SMAD3; 	AKT2|IDBG-51270|ENSG00000105221|208|; JUN|IDBG-99221|ENSG00000177606|3725|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Regulation of actin dynamics for phagocytic cup formation	13005	REACTOME	9606	3	66	0.11667899704086704	0.16339851330979738	ACTG1; ACTR3; NCKIPSD; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ACTR3|IDBG-67369|ENSG00000115091|10096|; NCKIPSD|IDBG-239383|ENSG00000213672|51517|; 
Assembly of the pre-replicative complex	12961	REACTOME	9606	3	67	0.12061459774214026	0.16787582787783603	GMNN; MCM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cytosolic sensors of pathogen-associated DNA 	19557	REACTOME	9606	3	67	0.12061459774214026	0.16787582787783603	APP; EP300; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Epithelial cell signaling in Helicobacter pylori infection	457	KEGG	9606	3	67	0.12061459774214026	0.16787582787783603	EGFR; JUN; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Signaling by FGFR	13320	REACTOME	9606	5	145	0.12208468855891952	0.16854606801049213	AKT2; EGFR; JAK2; KRAS; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; UBC|IDBG-64029|ENSG00000150991|7316|; 
GTP hydrolysis and joining of the 60S ribosomal subunit	13444	REACTOME	9606	4	105	0.12204014125319773	0.16882632116568125	EIF1AX; EIF5; EIF5B; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF5|IDBG-21484|ENSG00000100664|1983|; EIF5B|IDBG-63343|ENSG00000158417|9669|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Orphan transporters	18365	REACTOME	9606	4	105	0.12204014125319773	0.16882632116568125	NCOA2; NCOA6; TBL1X; TBL1XR1; 	NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
VEGFA-VEGFR2 Pathway	18745	REACTOME	9606	4	105	0.12204014125319773	0.16882632116568125	ACTG1; AKT2; JAK2; KRAS; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
LKB1 signaling events	15286	PID NCI	9606	2	34	0.12521522508631952	0.17217093449368934	ESR1; MAPT; 	ESR1|IDBG-97997|ENSG00000091831|2099|; MAPT|IDBG-55163|ENSG00000186868|4137|; 
Trefoil factors initiate mucosal healing	4063	PID BIOCARTA	9606	2	34	0.12521522508631952	0.17217093449368934	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Mitotic Prophase	18847	REACTOME	9606	4	107	0.1282865362605026	0.17568557777040716	CCNB2; HIST2H2AC; HIST2H2BE; HIST3H3; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; 
T cell receptor signaling pathway	563	KEGG	9606	4	107	0.1282865362605026	0.17568557777040716	AKT2; JUN; KRAS; MAP3K7; 	AKT2|IDBG-51270|ENSG00000105221|208|; JUN|IDBG-99221|ENSG00000177606|3725|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
FRS2-mediated cascade	13310	REACTOME	9606	2	35	0.1312978102408049	0.17873274767311165	JAK2; KRAS; 	JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
IL11	16509	NETPATH	9606	2	35	0.1312978102408049	0.17873274767311165	JAK2; SRC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SRC|IDBG-74081|ENSG00000197122|6714|; 
TWEAK	15930	NETPATH	9606	2	35	0.1312978102408049	0.17873274767311165	AKT2; MAP3K7; 	AKT2|IDBG-51270|ENSG00000105221|208|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
NGF signalling via TRKA from the plasma membrane	18753	REACTOME	9606	6	191	0.13211702964060823	0.17948966975078648	AKT2; EGFR; JAK2; KRAS; RALB; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
RIG-I-like receptor signaling pathway	5713	KEGG	9606	3	70	0.13270780052910655	0.17993383690029954	CYLD; MAP3K7; PIN1; 	CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; PIN1|IDBG-26087|ENSG00000127445|5300|; 
NCAM signaling for neurite out-growth	13914	REACTOME	9606	3	71	0.13683021465822365	0.18515517142243756	CACNB3; JAK2; KRAS; 	CACNB3|IDBG-30418|ENSG00000167535|784|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
TNF receptor signaling pathway	15154	PID NCI	9606	2	36	0.13744705156004552	0.18562156270089317	CYLD; MAP3K7; 	CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
Melanoma	490	KEGG	9606	3	72	0.1409962360453479	0.1896635759032096	AKT2; EGFR; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Removal of licensing factors from origins	12932	REACTOME	9606	3	72	0.1409962360453479	0.1896635759032096	GMNN; MCM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Activation of ATR in response to replication stress	12901	REACTOME	9606	2	37	0.14365859288446745	0.19248558024991513	DBF4; MCM2; 	DBF4|IDBG-25283|ENSG00000006634|10926|; MCM2|IDBG-54871|ENSG00000073111|4171|; 
IL2-mediated signaling events	15044	PID NCI	9606	2	37	0.14365859288446745	0.19248558024991513	JUN; SHC1; 	JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Resolution of Sister Chromatid Cohesion	12939	REACTOME	9606	4	112	0.14446919525686996	0.19319213953957903	CCNB2; MIS12; NUDC; TUBA4A; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; MIS12|IDBG-21731|ENSG00000167842|79003|; NUDC|IDBG-94765|ENSG00000090273|10726|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Bladder cancer	514	KEGG	9606	2	38	0.14992821205954968	0.1985457099507046	EGFR; KRAS; 	EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Cysteine and methionine metabolism	4362	KEGG	9606	2	38	0.14992821205954968	0.1985457099507046	AHCYL1; AHCYL2; 	AHCYL1|IDBG-100935|ENSG00000168710|10768|; AHCYL2|IDBG-40716|ENSG00000158467|23382|; 
Inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages	4022	PID BIOCARTA	9606	2	38	0.14992821205954968	0.1985457099507046	CSNK2A1; LRP6; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	15219	PID NCI	9606	2	38	0.14992821205954968	0.1985457099507046	EGFR; SRC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Downstream signaling events of B Cell Receptor (BCR)	19698	REACTOME	9606	5	155	0.14915882417699172	0.199073029527805	AKT2; EGFR; KRAS; MAP3K7; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by VEGF	17346	REACTOME	9606	4	114	0.1511577984888039	0.19978608249876792	ACTG1; AKT2; JAK2; KRAS; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Regulation of DNA replication	19523	REACTOME	9606	3	75	0.15374353760712173	0.2028106240774797	GMNN; MCM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
BCR	15916	NETPATH	9606	5	157	0.154859360027585	0.20388819215987058	CD81; HNRNPK; JUN; MAP3K7; SHC1; 	CD81|IDBG-22455|ENSG00000110651|975|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; JUN|IDBG-99221|ENSG00000177606|3725|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Hedgehog	15914	NETPATH	9606	2	39	0.1562518175336254	0.2049302683806395	GAS1; YWHAE; 	GAS1|IDBG-74874|ENSG00000180447|2619|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
RNA Polymerase I Promoter Opening	13737	REACTOME	9606	2	39	0.1562518175336254	0.2049302683806395	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Cell Cycle Checkpoints	19894	REACTOME	9606	4	117	0.16140797081939656	0.2112864416484231	CCNB2; DBF4; MCM2; UBC; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; DBF4|IDBG-25283|ENSG00000006634|10926|; MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Aldosterone-regulated sodium reabsorption	8110	KEGG	9606	2	40	0.16262544511070595	0.21206606800287087	KRAS; SLC9A3R2; 	KRAS|IDBG-23889|ENSG00000133703|3845|; SLC9A3R2|IDBG-9763|ENSG00000065054|9351|; 
Bacterial invasion of epithelial cells	10364	KEGG	9606	3	77	0.16243705410909043	0.2122261894681986	ACTG1; SHC1; SRC; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Cleavage of Growing Transcript in the Termination Region 	13761	REACTOME	9606	2	41	0.16904525469060822	0.21918034923763272	SRSF3; SRSF9; 	SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
DNA methylation	18620	REACTOME	9606	2	41	0.16904525469060822	0.21918034923763272	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
RNA Polymerase II Transcription Termination	17068	REACTOME	9606	2	41	0.16904525469060822	0.21918034923763272	SRSF3; SRSF9; 	SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
Signaling by FGFR in disease	16656	REACTOME	9606	5	162	0.16949767573883168	0.2193499333090763	AKT2; EGFR; JAK2; KRAS; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; UBC|IDBG-64029|ENSG00000150991|7316|; 
AMER1 mutants destabilize the destruction complex	16848	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
APC truncation mutants are not K63 polyubiquitinated	16833	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
APC truncation mutants have impaired AXIN binding	17628	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
AXIN missense mutants destabilize the destruction complex	17110	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
AXIN mutants destabilize the destruction complex, activating WNT signaling	16826	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Degradation of beta-catenin by the destruction complex	13328	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IL2	15918	NETPATH	9606	3	81	0.18024855555943795	0.22432393228382605	JAK2; JUN; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
S33 mutants of beta-catenin aren't phosphorylated	18561	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
S37 mutants of beta-catenin aren't phosphorylated	19772	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
S45 mutants of beta-catenin aren't phosphorylated	18114	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
T41 mutants of beta-catenin aren't phosphorylated	17841	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TCF7L2 mutants don't bind CTBP	19152	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
deletions in the AMER1 gene destabilize the destruction complex	18145	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling	19027	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
misspliced GSK3beta mutants stabilize beta-catenin	18097	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	18661	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
truncated APC mutants destabilize the destruction complex	16689	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
truncations of AMER1 destabilize the destruction complex	18627	REACTOME	9606	3	81	0.18024855555943795	0.22432393228382605	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Gap junction trafficking	18109	REACTOME	9606	2	43	0.18200866119827636	0.2256907398858627	ACTG1; TUBA4A; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
IL6-mediated signaling events	15826	PID NCI	9606	2	43	0.18200866119827636	0.2256907398858627	JAK2; JUN; 	JAK2|IDBG-47039|ENSG00000096968|3717|; JUN|IDBG-99221|ENSG00000177606|3725|; 
Insulin Pathway	15835	PID NCI	9606	2	42	0.1755075271366553	0.2266972225515131	AKT2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
TSH	15927	NETPATH	9606	3	82	0.18478275643550943	0.2283004345815533	JAK2; SHC1; SRC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
p75 NTR receptor-mediated signalling	17826	REACTOME	9606	3	82	0.18478275643550943	0.2283004345815533	HDAC3; UBC; YWHAE; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	19264	REACTOME	9606	4	122	0.17903342875827066	0.23081436372994443	CHD3; CHD4; HIST2H2AC; HIST2H2BE; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Focal adhesion	546	KEGG	9606	6	210	0.17997516971678895	0.23159069008839633	ACTG1; AKT2; EGFR; JUN; SHC1; SRC; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Gap junction trafficking and regulation	19768	REACTOME	9606	2	44	0.18854517050914557	0.2316897410580852	ACTG1; TUBA4A; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Nfat and hypertrophy of the heart 	4058	PID BIOCARTA	9606	2	44	0.18854517050914557	0.2316897410580852	ACTA1; SHC1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
PLK1 signaling events	15874	PID NCI	9606	2	44	0.18854517050914557	0.2316897410580852	NUDC; ODF2; 	NUDC|IDBG-94765|ENSG00000090273|10726|; ODF2|IDBG-88092|ENSG00000136811|4957|; 
Negative epigenetic regulation of rRNA expression	19850	REACTOME	9606	3	84	0.19394032470719696	0.23789082994659771	HIST2H2AC; HIST2H2BE; SIRT1; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; SIRT1|IDBG-75847|ENSG00000096717|23411|; 
Calcineurin-regulated NFAT-dependent transcription in lymphocytes	15231	PID NCI	9606	2	45	0.19511368064078666	0.23890041328010145	EGR2; JUN; 	EGR2|IDBG-75626|ENSG00000122877|1959|; JUN|IDBG-99221|ENSG00000177606|3725|; 
Signaling by SCF-KIT	13325	REACTOME	9606	4	127	0.19727393631693696	0.24111258883181186	AKT2; EGFR; JAK2; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Alzheimer's disease	521	KEGG	9606	5	172	0.20029518478022426	0.24436729162810902	APBB1; APP; EIF2AK3; MAPT; NDUFS1; 	APBB1|IDBG-28785|ENSG00000166313|322|; APP|IDBG-1100|ENSG00000142192|351|; EIF2AK3|IDBG-60518|ENSG00000172071|9451|; MAPT|IDBG-55163|ENSG00000186868|4137|; NDUFS1|IDBG-79438|ENSG00000023228|4719|; 
Axon guidance	494	KEGG	9606	4	128	0.20098944384500578	0.24477642982552486	DPYSL2; DPYSL5; EPHB3; KRAS; 	DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; EPHB3|IDBG-68339|ENSG00000182580|2049|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Pre-NOTCH Expression and Processing	17056	REACTOME	9606	2	46	0.20171092625376247	0.24478087492004627	EP300; JUN; 	EP300|IDBG-8992|ENSG00000100393|2033|; JUN|IDBG-99221|ENSG00000177606|3725|; 
RNA Polymerase I Transcription Initiation	13738	REACTOME	9606	2	46	0.20171092625376247	0.24478087492004627	CHD3; CHD4; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; 
Platelet activation, signaling and aggregation	17662	REACTOME	9606	6	219	0.20479505365606482	0.2480821076259968	AKT2; APP; JAK2; SHC1; TUBA4A; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Nucleotide excision repair	2801	KEGG	9606	2	47	0.20833374827052092	0.2510311242411577	CUL4A; PCNA; 	CUL4A|IDBG-52956|ENSG00000139842|8451|; PCNA|IDBG-50801|ENSG00000132646|5111|; 
Validated transcriptional targets of deltaNp63 isoforms	15671	PID NCI	9606	2	47	0.20833374827052092	0.2510311242411577	CCNB2; DLX5; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; DLX5|IDBG-28081|ENSG00000105880|1749|; 
p53 pathway	15289	PID NCI	9606	2	47	0.20833374827052092	0.2510311242411577	HUWE1; PIN1; 	HUWE1|IDBG-70116|ENSG00000086758|10075|; PIN1|IDBG-26087|ENSG00000127445|5300|; 
Eukaryotic Translation Elongation	13453	REACTOME	9606	3	88	0.2125790499723558	0.255694730301846	EEF1A1; EEF1A2; RPS4Y1; 	EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; EEF1A2|IDBG-86175|ENSG00000101210|1917|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
EPH-ephrin mediated repulsion of cells	19071	REACTOME	9606	2	48	0.21497909118282182	0.2572205968187447	ACTG1; EPHB3; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; EPHB3|IDBG-68339|ENSG00000182580|2049|; 
Formation of the ternary complex, and subsequently, the 43S complex	13448	REACTOME	9606	2	48	0.21497909118282182	0.2572205968187447	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Notch signaling pathway	491	KEGG	9606	2	48	0.21497909118282182	0.2572205968187447	EP300; NCOR2; 	EP300|IDBG-8992|ENSG00000100393|2033|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
Fcgamma receptor (FCGR) dependent phagocytosis	18888	REACTOME	9606	3	89	0.21729936287046092	0.25954144567014775	ACTG1; ACTR3; NCKIPSD; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ACTR3|IDBG-67369|ENSG00000115091|10096|; NCKIPSD|IDBG-239383|ENSG00000213672|51517|; 
Deposition of new CENPA-containing nucleosomes at the centromere	12912	REACTOME	9606	2	49	0.22164400030537768	0.26288905775350885	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Il-2 receptor beta chain in t cell activation	4011	PID BIOCARTA	9606	2	49	0.22164400030537768	0.26288905775350885	PCNA; SHC1; 	PCNA|IDBG-50801|ENSG00000132646|5111|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Malaria	10359	KEGG	9606	2	49	0.22164400030537768	0.26288905775350885	CD81; ICAM1; 	CD81|IDBG-22455|ENSG00000110651|975|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
Nucleosome assembly	17736	REACTOME	9606	2	49	0.22164400030537768	0.26288905775350885	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Downstream signaling of activated FGFR	16879	REACTOME	9606	4	134	0.22370512955782396	0.26487308742784016	AKT2; EGFR; JAK2; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
JAK STAT pathway and regulation	16125	INOH	9606	7	273	0.22434499911351247	0.26517034557264385	AKT2; CSNK1E; EGFR; JAK2; KRAS; MAP3K7; SRC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SRC|IDBG-74081|ENSG00000197122|6714|; 
EPH-Ephrin signaling	19189	REACTOME	9606	3	91	0.22680476792189108	0.26715173009107035	ACTG1; ACTR3; EPHB3; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ACTR3|IDBG-67369|ENSG00000115091|10096|; EPHB3|IDBG-68339|ENSG00000182580|2049|; 
Progesterone-mediated oocyte maturation	5712	KEGG	9606	3	91	0.22680476792189108	0.26715173009107035	AKT2; CCNB2; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; CCNB2|IDBG-14456|ENSG00000157456|9133|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Apoptotic execution  phase	13421	REACTOME	9606	2	50	0.2283256192402644	0.26847943503769023	KPNB1; MAPT; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; MAPT|IDBG-55163|ENSG00000186868|4137|; 
Chemokine signaling pathway	4389	KEGG	9606	5	181	0.22951387906626242	0.2694121609693476	AKT2; JAK2; KRAS; SHC1; SRC; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Hedgehog signaling pathway	449	KEGG	9606	2	51	0.2350211872762571	0.27493044549298	CSNK1E; GAS1; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; GAS1|IDBG-74874|ENSG00000180447|2619|; 
Lysine degradation	558	KEGG	9606	2	51	0.2350211872762571	0.27493044549298	MLL; NSD1; 	MLL|IDBG-73725|ENSG00000118058|4297|; NSD1|IDBG-59534|ENSG00000165671|64324|; 
RAC1 signaling pathway	15344	PID NCI	9606	2	52	0.24172803690844458	0.2818094379001012	ACTR3; JUN; 	ACTR3|IDBG-67369|ENSG00000115091|10096|; JUN|IDBG-99221|ENSG00000177606|3725|; 
Signaling events mediated by Stem cell factor receptor (c-Kit)	15404	PID NCI	9606	2	52	0.24172803690844458	0.2818094379001012	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Notch signaling pathway	15899	PID NCI	9606	2	53	0.24844359141814992	0.28914424803272737	EP300; LNX1; 	EP300|IDBG-8992|ENSG00000100393|2033|; LNX1|IDBG-18546|ENSG00000072201|84708|; 
Signaling by the B Cell Receptor (BCR)	19561	REACTOME	9606	5	188	0.2530510839627787	0.2940048369039439	AKT2; EGFR; KRAS; MAP3K7; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
T cell receptor signaling pathway	4156	PID BIOCARTA	9606	2	54	0.2551653624933432	0.2959571041164287	JUN; SHC1; 	JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Translation initiation complex formation	13445	REACTOME	9606	2	55	0.261890947882107	0.3032421501792818	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	13446	REACTOME	9606	2	56	0.2686180291382396	0.3094552295139855	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Viral myocarditis	8123	KEGG	9606	2	56	0.2686180291382396	0.3094552295139855	ACTG1; ICAM1; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
degradation of DVL	17694	REACTOME	9606	2	56	0.2686180291382396	0.3094552295139855	CUL3; UBC; 	CUL3|IDBG-82331|ENSG00000036257|8452|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Downstream signal transduction	13329	REACTOME	9606	4	146	0.27091162929311047	0.31157121615160427	AKT2; EGFR; JAK2; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
DAP12 signaling	13003	REACTOME	9606	4	147	0.27492869587380264	0.31565887304029194	AKT2; EGFR; JAK2; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
CDT1 association with the CDC6:ORC:origin complex	12959	REACTOME	9606	2	58	0.2820678113558126	0.32331134007506585	GMNN; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Beta1 integrin cell surface interactions	14944	PID NCI	9606	2	60	0.2954977549622705	0.3358824481404475	CD81; IGSF8; 	CD81|IDBG-22455|ENSG00000110651|975|; IGSF8|IDBG-103984|ENSG00000162729|93185|; 
Cell death signalling via NRAGE, NRIF and NADE	18983	REACTOME	9606	2	60	0.2954977549622705	0.3358824481404475	UBC; YWHAE; 	UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Fc-epsilon receptor I signaling in mast cells	15695	PID NCI	9606	2	60	0.2954977549622705	0.3358824481404475	JUN; SHC1; 	JUN|IDBG-99221|ENSG00000177606|3725|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
PI3K Cascade	13278	REACTOME	9606	2	60	0.2954977549622705	0.3358824481404475	AKT2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Phagosome	10394	KEGG	9606	4	152	0.2951557103715753	0.3377452927406281	ACTG1; HGS; TUBA4A; TUBB8; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; HGS|IDBG-72504|ENSG00000185359|9146|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; TUBB8|IDBG-777287|ENSG00000261456|347688|; 
CDC42 signaling events	15467	PID NCI	9606	2	61	0.30220032022844334	0.342929481523791	ACTR3; JUN; 	ACTR3|IDBG-67369|ENSG00000115091|10096|; JUN|IDBG-99221|ENSG00000177606|3725|; 
DAP12 interactions	13004	REACTOME	9606	4	155	0.30738579924089976	0.3482344104357037	AKT2; EGFR; JAK2; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Shigellosis	10374	KEGG	9606	2	62	0.3088921103131941	0.3493605625764484	ACTG1; SRC; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Interferon gamma signaling	13077	REACTOME	9606	2	63	0.315571334261884	0.3563239237857697	ICAM1; JAK2; 	ICAM1|IDBG-26804|ENSG00000090339|3383|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
RNA Polymerase I Chain Elongation	13735	REACTOME	9606	2	65	0.32888525553521375	0.3707433789669682	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
DNA Repair	19821	REACTOME	9606	3	112	0.3297889764585723	0.3711486500738388	PCNA; RAD51; UBC; 	PCNA|IDBG-50801|ENSG00000132646|5111|; RAD51|IDBG-6509|ENSG00000051180|5888|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Activation of NF-kappaB in B cells	13094	REACTOME	9606	2	66	0.33551670110723664	0.3763526153867358	MAP3K7; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Semaphorin interactions	17105	REACTOME	9606	2	66	0.33551670110723664	0.3763526153867358	DPYSL2; DPYSL5; 	DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; 
Long-term potentiation	507	KEGG	9606	2	67	0.3421290735207373	0.38313961927938067	EP300; KRAS; 	EP300|IDBG-8992|ENSG00000100393|2033|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Regulation of actin cytoskeleton	404	KEGG	9606	5	217	0.3553334270161065	0.3972744216803027	ACTG1; EGFR; KRAS; SRC; TMSB4Y; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; EGFR|IDBG-16933|ENSG00000146648|1956|; KRAS|IDBG-23889|ENSG00000133703|3845|; SRC|IDBG-74081|ENSG00000197122|6714|; TMSB4Y|IDBG-220|ENSG00000154620|9087|; 
Adipocytokine signaling pathway	590	KEGG	9606	2	70	0.3618373300230927	0.40256616488702973	AKT2; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Orc1 removal from chromatin	12931	REACTOME	9606	2	70	0.3618373300230927	0.40256616488702973	MCM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Switching of origins to a post-replicative state	12947	REACTOME	9606	2	70	0.3618373300230927	0.40256616488702973	MCM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Fc epsilon RI signaling pathway	435	KEGG	9606	2	71	0.36835927539638424	0.40848947287859194	AKT2; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	13066	REACTOME	9606	2	71	0.36835927539638424	0.40848947287859194	CD81; ICAM1; 	CD81|IDBG-22455|ENSG00000110651|975|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
Protein processing in endoplasmic reticulum	10363	KEGG	9606	4	171	0.3731779835382458	0.41316133891734363	DNAJB1; EIF2AK3; FBXO6; HSPH1; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; EIF2AK3|IDBG-60518|ENSG00000172071|9451|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HSPH1|IDBG-21616|ENSG00000120694|10808|; 
Separation of Sister Chromatids	12942	REACTOME	9606	4	173	0.3814082676066184	0.4209068584267213	MIS12; NUDC; TUBA4A; UBC; 	MIS12|IDBG-21731|ENSG00000167842|79003|; NUDC|IDBG-94765|ENSG00000090273|10726|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Constitutive PI3K/AKT Signaling in Cancer	13715	REACTOME	9606	2	73	0.3813243971220952	0.4214963352305818	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Signaling by PDGF	13330	REACTOME	9606	4	174	0.3855196358009858	0.4247566908178874	AKT2; EGFR; JAK2; KRAS; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	4353	KEGG	9606	2	74	0.3877652376730083	0.42654176144030914	ACTG1; CACNB3; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; CACNB3|IDBG-30418|ENSG00000167535|784|; 
Integrin signaling pathway	16138	INOH	9606	3	126	0.3988786717659868	0.4373557140585257	KRAS; SHC1; SRC; 	KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; SRC|IDBG-74081|ENSG00000197122|6714|; 
Systemic lupus erythematosus	2805	KEGG	9606	3	126	0.3988786717659868	0.4373557140585257	HIST2H2AC; HIST2H2BE; HIST3H3; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; 
Transcriptional regulation by small RNAs	17771	REACTOME	9606	2	76	0.4005580128080387	0.4384920782264565	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Platelet degranulation 	13130	REACTOME	9606	2	78	0.41322551552377706	0.4509116825395455	APP; TUBA4A; 	APP|IDBG-1100|ENSG00000142192|351|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Validated targets of C-MYC transcriptional activation	15279	PID NCI	9606	2	78	0.41322551552377706	0.4509116825395455	HUWE1; SMAD3; 	HUWE1|IDBG-70116|ENSG00000086758|10075|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Mitotic Anaphase	18656	REACTOME	9606	4	181	0.41418997235126537	0.451242110452976	MIS12; NUDC; TUBA4A; UBC; 	MIS12|IDBG-21731|ENSG00000167842|79003|; NUDC|IDBG-94765|ENSG00000090273|10726|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Natural killer cell mediated cytotoxicity	578	KEGG	9606	3	130	0.4183196683140542	0.45428983087609076	ICAM1; KRAS; SHC1; 	ICAM1|IDBG-26804|ENSG00000090339|3383|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Mitotic Metaphase and Anaphase	19900	REACTOME	9606	4	182	0.41826533249238096	0.4549552739390811	MIS12; NUDC; TUBA4A; UBC; 	MIS12|IDBG-21731|ENSG00000167842|79003|; NUDC|IDBG-94765|ENSG00000090273|10726|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
NoRC negatively regulates rRNA expression	17921	REACTOME	9606	2	81	0.4319757891261514	0.46763093362545277	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Unfolded Protein Response (UPR)	16784	REACTOME	9606	2	81	0.4319757891261514	0.46763093362545277	EIF2AK3; SHC1; 	EIF2AK3|IDBG-60518|ENSG00000172071|9451|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Hypertrophic cardiomyopathy (HCM)	4395	KEGG	9606	2	83	0.444299035637198	0.47944927579836877	ACTG1; CACNB3; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; CACNB3|IDBG-30418|ENSG00000167535|784|; 
Response to elevated platelet cytosolic Ca2+	13131	REACTOME	9606	2	83	0.444299035637198	0.47944927579836877	APP; TUBA4A; 	APP|IDBG-1100|ENSG00000142192|351|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Peptide chain elongation	13452	REACTOME	9606	2	84	0.4504053456672407	0.48527084635870166	EEF1A1; RPS4Y1; 	EEF1A1|IDBG-92423|ENSG00000156508|102724204,1915|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
PI-3K cascade	13309	REACTOME	9606	2	85	0.4564738764995261	0.4871912109118573	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PI3K events in ERBB2 signaling	13286	REACTOME	9606	2	85	0.4564738764995261	0.4871912109118573	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PI3K events in ERBB4 signaling	13263	REACTOME	9606	2	85	0.4564738764995261	0.4871912109118573	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PI3K/AKT Signaling in Cancer	19195	REACTOME	9606	2	85	0.4564738764995261	0.4871912109118573	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PIP3 activates AKT signaling	12989	REACTOME	9606	2	85	0.4564738764995261	0.4871912109118573	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Regulation of mRNA stability by proteins that bind AU-rich elements	19008	REACTOME	9606	2	85	0.4564738764995261	0.4871912109118573	UBC; YWHAZ; 	UBC|IDBG-64029|ENSG00000150991|7316|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
GAB1 signalosome	13212	REACTOME	9606	2	88	0.4744466412818741	0.5040071796794986	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PI3K/AKT activation	13178	REACTOME	9606	2	88	0.4744466412818741	0.5040071796794986	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Regulatory RNA pathways	19919	REACTOME	9606	2	88	0.4744466412818741	0.5040071796794986	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Factors involved in megakaryocyte development and platelet production	13101	REACTOME	9606	3	142	0.47527728105103556	0.504104363416495	EP300; JAK2; TUBA4A; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Insulin signaling pathway	531	KEGG	9606	3	143	0.47991335772748567	0.5082312266617162	AKT2; KRAS; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Dilated cardiomyopathy	5714	KEGG	9606	2	90	0.48622890091499815	0.5141211014326027	ACTG1; CACNB3; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; CACNB3|IDBG-30418|ENSG00000167535|784|; 
Formation of a pool of free 40S subunits	13447	REACTOME	9606	2	94	0.5092972504295805	0.5376791405463992	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Cell surface interactions at the vascular wall	13112	REACTOME	9606	2	98	0.5316836373238556	0.5604455033305558	KRAS; SHC1; 	KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Gastrin-CREB signalling pathway via PKC and MAPK	13219	REACTOME	9606	4	212	0.5361376421653798	0.5642683209209708	APP; EGFR; JAK2; KRAS; 	APP|IDBG-1100|ENSG00000142192|351|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Metabolism of lipids and lipoproteins	16920	REACTOME	9606	10	554	0.5481912974609003	0.5725366996452282	EP300; HDAC3; KPNB1; NCOA2; NCOA6; NCOR1; NCOR2; SP1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; KPNB1|IDBG-56053|ENSG00000108424|3837|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Melanogenesis	595	KEGG	9606	2	101	0.5480144465200744	0.573229835163636	EP300; KRAS; 	EP300|IDBG-8992|ENSG00000100393|2033|; KRAS|IDBG-23889|ENSG00000133703|3845|; 
Role of LAT2/NTAL/LAB on calcium mobilization	17405	REACTOME	9606	2	101	0.5480144465200744	0.573229835163636	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Stimuli-sensing channels	13099	REACTOME	9606	2	101	0.5480144465200744	0.573229835163636	SLC9B1; UBC; 	SLC9B1|IDBG-32332|ENSG00000164037|150159|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Jak-STAT signaling pathway	568	KEGG	9606	3	158	0.5469815129786318	0.5747941322826301	AKT2; EP300; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
RNA Polymerase II Transcription	18434	REACTOME	9606	2	102	0.5533694233827425	0.5770610806529517	SRSF3; SRSF9; 	SRSF3|IDBG-84998|ENSG00000112081|6428|; SRSF9|IDBG-60612|ENSG00000111786|283459,8683|; 
L13a-mediated translational silencing of Ceruloplasmin expression	13096	REACTOME	9606	2	104	0.563945414687746	0.5862969097820773	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Pyrimidine metabolism	409	KEGG	9606	2	104	0.563945414687746	0.5862969097820773	PRIM1; PRIM2; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
MHC class II antigen presentation	13065	REACTOME	9606	2	111	0.5995435437914995	0.6223572250621046	DYNLL1; TUBA4A; 	DYNLL1|IDBG-60661|ENSG00000088986|8655|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Hedgehog 'off' state	18085	REACTOME	9606	2	112	0.6044481722914004	0.6264949141378952	TUBA4A; UBC; 	TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Purine metabolism	503	KEGG	9606	3	174	0.6127006733592895	0.6340847636282783	PRIM1; PRIM2; PRPS1; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; PRPS1|IDBG-81487|ENSG00000147224|5631|; 
Leukocyte transendothelial migration	510	KEGG	9606	2	120	0.642060121855373	0.6634621259172188	ACTG1; ICAM1; 	ACTG1|IDBG-72264|ENSG00000184009|60,71|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
Host Interactions of HIV factors	19514	REACTOME	9606	2	121	0.6465595241116608	0.6671007495372961	KPNB1; UBC; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by Hedgehog	16836	REACTOME	9606	2	128	0.6768154449916723	0.6972630415171005	TUBA4A; UBC; 	TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Influenza Life Cycle	19285	REACTOME	9606	2	131	0.6891270272711361	0.7088757656092228	KPNB1; RPS4Y1; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Huntington's disease	4392	KEGG	9606	3	198	0.6987483416091538	0.7176903147250645	EP300; NDUFS1; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; NDUFS1|IDBG-79438|ENSG00000023228|4719|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Hemostasis	19856	REACTOME	9606	8	508	0.7054993666052165	0.723534688759034	AKT2; APP; EP300; JAK2; KRAS; SHC1; TUBA4A; YWHAZ; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAZ|IDBG-30919|ENSG00000164924|7534|; 
Influenza Infection	16853	REACTOME	9606	2	136	0.7087921678698414	0.7258202079387865	KPNB1; RPS4Y1; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
beta-catenin independent WNT signaling	17081	REACTOME	9606	2	143	0.7345779508408203	0.7510976948627278	MAP3K7; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cell adhesion molecules (CAMs)	440	KEGG	9606	2	144	0.7380997466947808	0.7535689030626356	ICAM1; NLGN3; 	ICAM1|IDBG-26804|ENSG00000090339|3383|; NLGN3|IDBG-75254|ENSG00000196338|54413|; 
Parkinson's disease	2812	KEGG	9606	2	149	0.7551191194833151	0.7697925851832897	LRRK2; NDUFS1; 	LRRK2|IDBG-27257|ENSG00000188906|120892|; NDUFS1|IDBG-79438|ENSG00000023228|4719|; 
Ion channel transport	18537	REACTOME	9606	2	169	0.8139973502250342	0.82857640724399	SLC9B1; UBC; 	SLC9B1|IDBG-32332|ENSG00000164037|150159|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Glycogen storage diseases	19851	REACTOME	9606	3	253	0.8404721930736744	0.8517117914951647	HS2ST1; PRPS1; UBC; 	HS2ST1|IDBG-100108|ENSG00000153936|9653|; PRPS1|IDBG-81487|ENSG00000147224|5631|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Metabolism of carbohydrates	17445	REACTOME	9606	3	253	0.8404721930736744	0.8517117914951647	HS2ST1; PRPS1; UBC; 	HS2ST1|IDBG-100108|ENSG00000153936|9653|; PRPS1|IDBG-81487|ENSG00000147224|5631|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Myoclonic epilepsy of Lafora	17077	REACTOME	9606	3	253	0.8404721930736744	0.8517117914951647	HS2ST1; PRPS1; UBC; 	HS2ST1|IDBG-100108|ENSG00000153936|9653|; PRPS1|IDBG-81487|ENSG00000147224|5631|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Calcium signaling pathway	594	KEGG	9606	2	183	0.8473837493314622	0.8574417166825775	EGFR; HTR7; 	EGFR|IDBG-16933|ENSG00000146648|1956|; HTR7|IDBG-82120|ENSG00000148680|3363|; 
HIV Infection	19164	REACTOME	9606	2	209	0.8953566957151436	0.9046418762633007	KPNB1; UBC; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Extracellular matrix organization	17095	REACTOME	9606	2	266	0.9558911956114771	0.9643754369926439	APP; ICAM1; 	APP|IDBG-1100|ENSG00000142192|351|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
Transmembrane transport of small molecules	16726	REACTOME	9606	6	606	0.9667653157765654	0.9739053845784604	NCOA2; NCOA6; SLC9B1; TBL1X; TBL1XR1; UBC; 	NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; SLC9B1|IDBG-32332|ENSG00000164037|150159|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Class A/1 (Rhodopsin-like receptors)	13250	REACTOME	9606	2	307	0.9768783876822229	0.9826416820048319	APP; HTR7; 	APP|IDBG-1100|ENSG00000142192|351|; HTR7|IDBG-82120|ENSG00000148680|3363|; 
GPCR downstream signaling	18003	REACTOME	9606	5	923	0.9998704987728713	0.9998704987728713	AKT2; APP; HTR7; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; HTR7|IDBG-82120|ENSG00000148680|3363|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
GPCR ligand binding	19266	REACTOME	9606	2	433	0.9971034866197237	1.0	APP; HTR7; 	APP|IDBG-1100|ENSG00000142192|351|; HTR7|IDBG-82120|ENSG00000148680|3363|; 
Metabolism	19429	REACTOME	9606	15	1535	0.998497324306384	1.0	CACNB3; EP300; HDAC3; HS2ST1; KPNB1; NCOA2; NCOA6; NCOR1; NCOR2; NDUFS1; PRPS1; SP1; TBL1X; TBL1XR1; UBC; 	CACNB3|IDBG-30418|ENSG00000167535|784|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HS2ST1|IDBG-100108|ENSG00000153936|9653|; KPNB1|IDBG-56053|ENSG00000108424|3837|; NCOA2|IDBG-24827|ENSG00000140396|10499|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; NDUFS1|IDBG-79438|ENSG00000023228|4719|; PRPS1|IDBG-81487|ENSG00000147224|5631|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by GPCR	17449	REACTOME	9606	7	1035	0.9996518732092107	1.0	AKT2; APP; EGFR; HTR7; JAK2; KRAS; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; EGFR|IDBG-16933|ENSG00000146648|1956|; HTR7|IDBG-82120|ENSG00000148680|3363|; JAK2|IDBG-47039|ENSG00000096968|3717|; KRAS|IDBG-23889|ENSG00000133703|3845|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
